Carboxyl-terminal	B-protein
15-amino	I-protein
acid	I-protein
sequence	I-protein
of	O
NFATx1	B-protein
is	O
possibly	O
created	O
by	O
tissue-specific	O
splicing	O
and	O
is	O
essential	O
for	O
transactivation	O
activity	O
in	O
T	B-cell_type
cells	I-cell_type
.	O

NFAT	B-protein
regulates	O
transcription	O
of	O
a	O
number	O
of	O
cytokine	O
and	O
other	O
immunoregulatory	B-DNA
genes	I-DNA
.	O

We	O
have	O
isolated	O
NFATx	B-protein
,	O
which	O
is	O
one	O
of	O
four	O
members	O
of	O
the	O
NFAT	B-protein
family	I-protein
of	O
transcription	B-protein
factors	I-protein
and	O
is	O
preferentially	O
expressed	O
in	O
the	O
thymus	O
and	O
peripheral	B-cell_type
blood	I-cell_type
leukocytes	I-cell_type
,	O
and	O
an	O
isoform	O
of	O
NFATx	B-protein
,	O
NFATx1	B-protein
.	O

Here	O
we	O
provide	O
evidence	O
showing	O
that	O
15	O
amino	O
acids	O
in	O
the	O
carboxyl-terminal	B-protein
end	I-protein
of	O
NFATx1	B-protein
are	O
required	O
for	O
its	O
maximum	O
transactivation	O
activity	O
in	O
Jurkat	B-cell_line
T	I-cell_line
cells	I-cell_line
.	O

A	O
fusion	O
between	O
these	O
15	O
amino	O
acids	O
and	O
the	O
GAL4	B-protein
DNA	I-protein
binding	I-protein
domain	I-protein
was	O
capable	O
of	O
transactivating	O
reporters	O
driven	O
by	O
the	O
GAL4	B-DNA
DNA	I-DNA
binding	I-DNA
site	I-DNA
.	O

Interestingly	O
,	O
this	O
15-amino	B-protein
acid	I-protein
transactivation	I-protein
sequence	I-protein
is	O
well	O
conserved	O
in	O
NFAT	B-protein
family	I-protein
proteins	I-protein
,	O
although	O
the	O
sequences	O
contiguous	O
to	O
the	O
carboxyl-terminal	B-protein
regions	I-protein
of	O
the	O
NFAT	B-protein
family	I-protein
are	O
much	O
less	O
conserved	O
.	O

We	O
also	O
report	O
three	O
additional	O
isoforms	O
of	O
NFATx	B-protein
,	O
designated	O
NFATx2	B-protein
,	O
NFATx3	B-protein
,	O
and	O
NFATx4	B-protein
.	O

This	O
transactivation	O
sequence	O
is	O
altered	O
by	O
tissue-specific	O
alternative	O
splicing	O
in	O
newly	O
isolated	O
NFATx	B-protein
isoforms	I-protein
,	O
resulting	O
in	O
lower	O
transactivation	O
activity	O
in	O
Jurkat	B-cell_line
T	I-cell_line
cells	I-cell_line
.	O

NFATx1	B-protein
is	O
expressed	O
predominantly	O
in	O
the	O
thymus	O
and	O
peripheral	B-cell_type
blood	I-cell_type
leukocyte	I-cell_type
,	O
while	O
the	O
skeletal	O
muscle	O
expressed	O
primarily	O
NFATx2	B-protein
.	O

In	O
Jurkat	B-cell_line
cells	I-cell_line
,	O
transcription	O
from	O
the	O
NFAT	B-DNA
site	I-DNA
of	O
the	O
IL-2	B-DNA
promoter	I-DNA
is	O
activated	O
strongly	O
by	O
NFATx1	B-protein
but	O
only	O
weakly	O
by	O
NFATx2	B-protein
.	O

These	O
data	O
demonstrate	O
that	O
the	O
15-amino	B-protein
acid	I-protein
sequence	I-protein
of	O
NFATx1	B-protein
is	O
a	O
major	B-protein
transactivation	I-protein
sequence	I-protein
required	O
for	O
induction	O
of	O
genes	O
by	O
NFATx1	B-protein
in	O
T	B-cell_type
cells	I-cell_type
and	O
possibly	O
regulates	O
NFAT	B-protein
activity	O
through	O
tissue-specific	O
alternative	O
splicing	O
.	O

Accelerating	NULL
Life	NULL
Sciences	NULL
.	NULL

2	NULL
nozzles	NULL
per	NULL
well	NULL
enable	NULL
cell	NULL
Cha	NULL
Check	NULL
out	NULL
how	NULL
Laminar	NULL
Wash	NULL
l	NULL
washing	NULL
by	NULL
creating	NULL
a	NULL
laminar	NULL
T	NULL
‘	NULL
.CU	NULL
RIOX	NULL
systems	NULL
replace	NULL
centrifugation	NULL
completely	NULL
in	NULL
handling	NULL
cells	NULL
See	NULL
How	NULL
It	NULL
Works	NULL
#	NULL
meJournal	NULL
of	NULL
Carboxyl-Terminal	NULL
15-Amino	NULL
Acid	NULL
Sequence	NULL
4D	NULL
Imnmunolo	NULL
gy	NULL
of	NULL
NFAT'x1	NULL
Is	NULL
Possibly	NULL
Created	NULL
by	NULL
Tissue-Specific	NULL
Splicing	NULL
and	NULL
Is	NULL
Essential	NULL
for	NULL
Transactivation	NULL
Activity	NULL
in	NULL
T	NULL
Cells	NULL
This	NULL
information	NULL
is	NULL
current	NULL
as	NULL
of	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

Ryu	NULL
Imamura	NULL
,	NULL
Esteban	NULL
S.	NULL
Masuda	NULL
,	NULL
Yoshiyuki	NULL
Naito	NULL
,	NULL
Shin-ichiro	NULL
Imai	NULL
,	NULL
Tadahiro	NULL
Fujino	NULL
,	NULL
Toshiya	NULL
Takano	NULL
,	NULL
Ken-ichi	NULL
Arai	NULL
and	NULL
Naoko	NULL
Arai	NULL
J	NULL
Immunol	NULL
1998	NULL
;	NULL
161:3455-3463	NULL
;	NULL
;	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/161/7/3455	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
42	NULL
articles	NULL
,	NULL
21	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/161/7/3455	NULL
full	NULL
#	NULL
ref-list-1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
Carboxyl-Terminal	NULL
15-Amino	NULL
Acid	NULL
Sequence	NULL
of	NULL
NFATx1	NULL
Is	NULL
Possibly	NULL
Created	NULL
by	NULL
Tissue-Specific	NULL
Splicing	NULL
and	NULL
Is	NULL
Essential	NULL
for	NULL
Transactivation	NULL
Activity	NULL
in	NULL
T	NULL
Cells	NULL
``	NULL
Ryu	NULL
Imamura	NULL
,	NULL
*	NULL
Esteban	NULL
S.	NULL
Masuda	NULL
,	NULL
*	NULL
Yoshiyuki	NULL
Naito	NULL
,	NULL
*	NULL
Shin-ichiro	NULL
Imai	NULL
,	NULL
``	NULL
Tadahiro	NULL
Fujino	NULL
,	NULL
``	NULL
Toshiya	NULL
Takano	NULL
,	NULL
``	NULL
Ken-ichi	NULL
Arai	NULL
,	NULL
*	NULL
and	NULL
Naoko	NULL
Arai'*	NULL
NFAT	NULL
regulates	NULL
transcription	NULL
of	NULL
a	NULL
number	NULL
of	NULL
cytokine	NULL
and	NULL
other	NULL
immunoregulatory	NULL
genes	NULL
.	NULL

We	NULL
have	NULL
isolated	NULL
NFATx	NULL
,	NULL
which	NULL
is	NULL
one	NULL
of	NULL
four	NULL
members	NULL
of	NULL
the	NULL
NFAT	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
and	NULL
is	NULL
preferentially	NULL
expressed	NULL
in	NULL
the	NULL
thymus	NULL
and	NULL
peripheral	NULL
blood	NULL
leukocytes	NULL
,	NULL
and	NULL
an	NULL
isoform	NULL
of	NULL
NFATx	NULL
,	NULL
NFATx1	NULL
.	NULL

Here	NULL
we	NULL
provide	NULL
evidence	NULL
showing	NULL
that	NULL
15	NULL
amino	NULL
acids	NULL
in	NULL
the	NULL
carboxyl-terminal	NULL
end	NULL
of	NULL
NFATx1	NULL
are	NULL
required	NULL
for	NULL
its	NULL
maximum	NULL
transactivation	NULL
activity	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

A	NULL
fusion	NULL
between	NULL
these	NULL
15	NULL
amino	NULL
acids	NULL
and	NULL
the	NULL
GAL4	NULL
DNA	NULL
binding	NULL
domain	NULL
was	NULL
capable	NULL
of	NULL
transactivating	NULL
reporters	NULL
driven	NULL
by	NULL
the	NULL
GAL4	NULL
DNA	NULL
binding	NULL
site	NULL
.	NULL

Interestingly	NULL
,	NULL
this	NULL
15-amino	NULL
acid	NULL
transactivation	NULL
sequence	NULL
is	NULL
well	NULL
conserved	NULL
in	NULL
NFAT	NULL
family	NULL
proteins	NULL
,	NULL
although	NULL
the	NULL
sequences	NULL
contiguous	NULL
to	NULL
the	NULL
carboxyl-terminal	NULL
regions	NULL
of	NULL
the	NULL
NFAT	NULL
family	NULL
are	NULL
much	NULL
less	NULL
conserved	NULL
.	NULL

We	NULL
also	NULL
report	NULL
three	NULL
additional	NULL
isoforms	NULL
of	NULL
NFAT	NULL
'	NULL
x	NULL
,	NULL
designated	NULL
NFATx2	NULL
,	NULL
NFATx3	NULL
,	NULL
and	NULL
NFATx4	NULL
.	NULL

This	NULL
transactivation	NULL
sequence	NULL
is	NULL
altered	NULL
by	NULL
tissue-specific	NULL
alternative	NULL
splicing	NULL
in	NULL
newly	NULL
isolated	NULL
NFAT	NULL
'	NULL
x	NULL
isoforms	NULL
,	NULL
resulting	NULL
in	NULL
lower	NULL
transactivation	NULL
activity	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

NFATx1	NULL
is	NULL
expressed	NULL
predominantly	NULL
in	NULL
the	NULL
thymus	NULL
and	NULL
peripheral	NULL
blood	NULL
leukocyte	NULL
,	NULL
while	NULL
the	NULL
skeletal	NULL
muscle	NULL
expressed	NULL
primarily	NULL
NFATx2	NULL
.	NULL

In	NULL
Jurkat	NULL
cells	NULL
,	NULL
transcription	NULL
from	NULL
the	NULL
NFAT	NULL
site	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
is	NULL
activated	NULL
strongly	NULL
by	NULL
NFATx1	NULL
but	NULL
only	NULL
weakly	NULL
by	NULL
NFATx2	NULL
.	NULL

These	NULL
data	NULL
demonstrate	NULL
that	NULL
the	NULL
15-amino	NULL
acid	NULL
sequence	NULL
of	NULL
NFATx1	NULL
is	NULL
a	NULL
major	NULL
transactivation	NULL
sequence	NULL
required	NULL
for	NULL
induction	NULL
of	NULL
genes	NULL
by	NULL
NFATx1	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
possibly	NULL
regulates	NULL
NFAT	NULL
activity	NULL
through	NULL
tissue-specific	NULL
alternative	NULL
splicing	NULL
.	NULL

The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
1998	NULL
,	NULL
161	NULL
:	NULL
3455-	NULL
3463.	NULL
specific	NULL
transcription	NULL
factor	NULL
in	NULL
the	NULL
IL-2	NULL
promoter	NULL
system	NULL
(	NULL
1	NULL
)	NULL
,	NULL
is	NULL
thought	NULL
to	NULL
regulate	NULL
transcriptional	NULL
induction	NULL
of	NULL
the	NULL
early	NULL
immune	NULL
response	NULL
genes	NULL
,	NULL
such	NULL
as	NULL
those	NULL
for	NULL
IL-2	NULL
,	NULL
IL-3	NULL
,	NULL
IL-4	NULL
,	NULL
IL-5	NULL
,	NULL
granulocyte-macrophage-CSF	NULL
,	NULL
TNF-a	NULL
,	NULL
CD40	NULL
ligand	NULL
,	NULL
and	NULL
Fas	NULL
ligand	NULL
(	NULL
2-4	NULL
)	NULL
.	NULL

NFAT	NULL
consists	NULL
of	NULL
two	NULL
components	NULL
:	NULL
a	NULL
pre-exist-ing	NULL
cytoplasmic	NULL
component	NULL
,	NULL
which	NULL
translocates	NULL
into	NULL
the	NULL
nucleus	NULL
upon	NULL
calcium	NULL
mobilization	NULL
,	NULL
and	NULL
an	NULL
inducible	NULL
nuclear	NULL
component	NULL
composed	NULL
of	NULL
members	NULL
of	NULL
the	NULL
activating	NULL
protein-1	NULL
(	NULL
AP-1	NULL
)	NULL
*	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
.	NULL

Translocation	NULL
of	NULL
the	NULL
cytoplasmic	NULL
component	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
calcium/calmodulin-dependent	NULL
phosphatase	NULL
calcineurin	NULL
and	NULL
is	NULL
sensitive	NULL
to	NULL
the	NULL
actions	NULL
of	NULL
the	NULL
immunosuppressants	NULL
cyclosporin	NULL
A	NULL
and	NULL
FK506	NULL
(	NULL
2	NULL
,	NULL
7	NULL
,	NULL
8	NULL
)	NULL
.	NULL

The	NULL
search	NULL
for	NULL
genes	NULL
encoding	NULL
cytoplasmic	NULL
components	NULL
of	NULL
NFAT	NULL
,	NULL
collectively	NULL
termed	NULL
NFAT	NULL
family	NULL
proteins	NULL
,	NULL
led	NULL
to	NULL
the	NULL
isolation	NULL
of	NULL
four	NULL
distinct	NULL
cDNAs	NULL
that	NULL
shared	NULL
sequence	NULL
similarities	NULL
.	NULL

T	NULL
he	NULL
multisubunit	NULL
NFAT	NULL
,	NULL
which	NULL
was	NULL
identified	NULL
as	NULL
a	NULL
T	NULL
cell	NULL
*Department	NULL
of	NULL
Cell	NULL
Signaling	NULL
,	NULL
DNAX	NULL
Research	NULL
Institute	NULL
of	NULL
Molecular	NULL
and	NULL
Cellular	NULL
Biology	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
94304	NULL
;	NULL
*Department	NULL
of	NULL
Microbiology	NULL
,	NULL
Keio	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Shinjuku-ku	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
;	NULL
and	NULL
*Department	NULL
of	NULL
Molecular	NULL
and	NULL
Developmental	NULL
Biology	NULL
,	NULL
Institute	NULL
of	NULL
Medical	NULL
Science	NULL
,	NULL
University	NULL
of	NULL
Tokyo	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
Received	NULL
for	NULL
publication	NULL
December	NULL
2	NULL
,	NULL
1997	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
May	NULL
29	NULL
,	NULL
1998	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
advertisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

*	NULL
DNAX	NULL
Research	NULL
Institute	NULL
of	NULL
Molecular	NULL
and	NULL
Cellular	NULL
Biology	NULL
is	NULL
supported	NULL
by	NULL
the	NULL
Schering-Plough	NULL
Corp	NULL
.	NULL

The	NULL
nucleic	NULL
acid	NULL
sequences	NULL
reported	NULL
in	NULL
this	NULL
paper	NULL
have	NULL
been	NULL
submitted	NULL
to	NULL
the	NULL
GenBank	NULL
with	NULL
accession	NULL
numbers	NULL
U85428	NULL
,	NULL
U85429	NULL
,	NULL
and	NULL
U85430	NULL
.	NULL

3	NULL
Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
Naoko	NULL
Arai	NULL
,	NULL
Department	NULL
of	NULL
Cell	NULL
Signaling	NULL
,	NULL
DNAX	NULL
Research	NULL
Institute	NULL
of	NULL
Molecular	NULL
and	NULL
Cellular	NULL
Biology	NULL
,	NULL
901	NULL
California	NULL
Ave.	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
94304-1104	NULL
.	NULL

E-mail	NULL
address	NULL
:	NULL
arai	NULL
@	NULL
dnax.org	NULL
*	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
AP-1	NULL
,	NULL
activating	NULL
protein-1	NULL
;	NULL
RSV	NULL
,	NULL
Rous	NULL
sarcoma	NULL
virus	NULL
;	NULL
SEAP	NULL
,	NULL
secreted	NULL
placental	NULL
alkaline	NULL
phosphatase	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

Copyright	NULL
©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
They	NULL
encoded	NULL
proteins	NULL
that	NULL
were	NULL
named	NULL
NFATI	NULL
(	NULL
NFATp	NULL
)	NULL
,	NULL
NFATc	NULL
,	NULL
NFATx/NFATA4/NFATc3	NULL
,	NULL
and	NULL
NFAT3	NULL
(	NULL
9-13	NULL
)	NULL
.	NULL

All	NULL
four	NULL
NFAT	NULL
proteins	NULL
can	NULL
activate	NULL
transcription	NULL
driven	NULL
by	NULL
the	NULL
NFAT	NULL
site	NULL
from	NULL
the	NULL
IL-2	NULL
promoter	NULL
(	NULL
9-12	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
individual	NULL
roles	NULL
of	NULL
NFAT	NULL
family	NULL
proteins	NULL
in	NULL
regulating	NULL
gene	NULL
expression	NULL
are	NULL
still	NULL
un-clear	NULL
.	NULL

NFAT	NULL
family	NULL
proteins	NULL
are	NULL
characterized	NULL
by	NULL
a	NULL
highly	NULL
homol-ogous	NULL
domain	NULL
,	NULL
which	NULL
is	NULL
weakly	NULL
related	NULL
to	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
Rel	NULL
family	NULL
proteins	NULL
(	NULL
9	NULL
,	NULL
10	NULL
,	NULL
14	NULL
,	NULL
15	NULL
)	NULL
.	NULL

The	NULL
existence	NULL
of	NULL
this	NULL
characteristic	NULL
Rel	NULL
similarity	NULL
domain	NULL
allowed	NULL
us	NULL
to	NULL
divide	NULL
NFAT	NULL
family	NULL
proteins	NULL
into	NULL
three	NULL
distinct	NULL
regions	NULL
:	NULL
an	NULL
amino-terminal	NULL
region	NULL
,	NULL
a	NULL
carboxyl-terminal	NULL
region	NULL
,	NULL
and	NULL
a	NULL
middle	NULL
region	NULL
containing	NULL
the	NULL
Rel	NULL
similarity	NULL
domain	NULL
.	NULL

The	NULL
main	NULL
function	NULL
of	NULL
the	NULL
Rel	NULL
similarity	NULL
domain	NULL
is	NULL
DNA	NULL
binding	NULL
and	NULL
protein-protein	NULL
interactions	NULL
with	NULL
the	NULL
AP-1	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

Indeed	NULL
,	NULL
the	NULL
Rel	NULL
similarity	NULL
domains	NULL
from	NULL
all	NULL
four	NULL
NFAT	NULL
family	NULL
proteins	NULL
are	NULL
capable	NULL
of	NULL
binding	NULL
cooperatively	NULL
with	NULL
AP-1	NULL
family	NULL
proteins	NULL
at	NULL
the	NULL
IL-2	NULL
promoter	NULL
NFAT	NULL
site	NULL
(	NULL
9	NULL
,	NULL
12	NULL
,	NULL
14	NULL
,	NULL
16	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
the	NULL
amino-terminal	NULL
region	NULL
of	NULL
NFATI	NULL
(	NULL
NFATp	NULL
)	NULL
and	NULL
NFATx/NFAT4	NULL
is	NULL
important	NULL
and	NULL
sufficient	NULL
for	NULL
binding	NULL
to	NULL
calcineurin	NULL
and	NULL
seems	NULL
to	NULL
regulate	NULL
nuclear	NULL
translocation	NULL
(	NULL
16-18	NULL
)	NULL
.	NULL

The	NULL
amino-terminal	NULL
region	NULL
shows	NULL
signifi-cant	NULL
,	NULL
albeit	NULL
weak	NULL
,	NULL
sequence	NULL
similarity	NULL
among	NULL
NFAT	NULL
family	NULL
proteins	NULL
and	NULL
is	NULL
characterized	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
three	NULL
perfect	NULL
repeats	NULL
for	NULL
NFATI	NULL
(	NULL
NFATp	NULL
)	NULL
,	NULL
NFATc	NULL
,	NULL
and	NULL
NFATx	NULL
and	NULL
one	NULL
for	NULL
NFAT3	NULL
,	NULL
containing	NULL
the	NULL
sequence	NULL
SPXXSPXXSPXXXXX	NULL
(	NULL
D	NULL
,	NULL
E	NULL
)	NULL
(	NULL
D	NULL
,	NULL
E	NULL
)	NULL
,	NULL
referred	NULL
to	NULL
as	NULL
SP	NULL
boxes	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
middle	NULL
and	NULL
the	NULL
amino-terminal	NULL
regions	NULL
,	NULL
little	NULL
is	NULL
known	NULL
about	NULL
the	NULL
carboxyl-terminal	NULL
region	NULL
,	NULL
which	NULL
shows	NULL
no	NULL
significant	NULL
sequence	NULL
similarities	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
carboxyl-terminal	NULL
region	NULL
is	NULL
absent	NULL
in	NULL
the	NULL
NFATc	NULL
protein	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
we	NULL
cloned	NULL
a	NULL
cDNA	NULL
encoding	NULL
a	NULL
member	NULL
of	NULL
the	NULL
NFAT	NULL
family	NULL
proteins	NULL
,	NULL
referred	NULL
to	NULL
as	NULL
NFAT	NULL
'	NULL
x	NULL
,	NULL
and	NULL
showed	NULL
that	NULL
NFAT	NULL
specifically	NULL
bound	NULL
the	NULL
NFAT	NULL
binding	NULL
sequence	NULL
,	NULL
that	NULL
it	NULL
was	NULL
capable	NULL
of	NULL
0022-1767/98/	NULL
$	NULL
02.00	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
3456	NULL
activating	NULL
the	NULL
IL-2	NULL
promoter	NULL
,	NULL
and	NULL
that	NULL
this	NULL
molecule	NULL
was	NULL
expressed	NULL
predominantly	NULL
in	NULL
the	NULL
thymus	NULL
(	NULL
10	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
work	NULL
we	NULL
identified	NULL
a	NULL
15-amino	NULL
acid	NULL
transactivation	NULL
sequence	NULL
in	NULL
the	NULL
carboxy-terminal	NULL
end	NULL
of	NULL
NFAT	NULL
'	NULL
x	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
isolated	NULL
cDNAs	NULL
encoding	NULL
three	NULL
isoforms	NULL
of	NULL
NFATx	NULL
,	NULL
ie	NULL
.	NULL

,	NULL
NFATx2	NULL
,	NULL
NFATx3	NULL
,	NULL
and	NULL
NFATx4	NULL
.	NULL

NFATx	NULL
was	NULL
renamed	NULL
NFATx1	NULL
.	NULL

Interestingly	NULL
,	NULL
these	NULL
isoforms	NULL
have	NULL
altered	NULL
carboxyl-terminal	NULL
ends	NULL
and	NULL
lost	NULL
NFATx1	NULL
transactivation	NULL
sequence	NULL
,	NULL
which	NULL
explains	NULL
the	NULL
strong	NULL
transactivation	NULL
activity	NULL
of	NULL
NFATx1	NULL
compared	NULL
with	NULL
those	NULL
of	NULL
the	NULL
other	NULL
isoforms	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
cDNA	NULL
cloning	NULL
cDNAs	NULL
encoding	NULL
NFATx2	NULL
and	NULL
NFATx3	NULL
were	NULL
isolated	NULL
by	NULL
screening	NULL
Jurkat	NULL
cDNA	NULL
libraries	NULL
in	NULL
AZiplox	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Gaithersburg	NULL
,	NULL
MD	NULL
)	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
10	NULL
)	NULL
.	NULL

NFATx4	NULL
was	NULL
isolated	NULL
by	NULL
screening	NULL
a	NULL
cDNA	NULL
library	NULL
obtained	NULL
from	NULL
T	NULL
Ag-transformed	NULL
human	NULL
diploid	NULL
fibroblasts	NULL
(	NULL
19	NULL
)	NULL
,	NULL
using	NULL
as	NULL
a	NULL
probe	NULL
a	NULL
DNA	NULL
fragment	NULL
spanning	NULL
the	NULL
whole	NULL
Rel	NULL
similarity	NULL
domain	NULL
of	NULL
human	NULL
NFATI	NULL
(	NULL
NFATp	NULL
)	NULL
.	NULL

Five	NULL
positive	NULL
cDNA	NULL
clones	NULL
,	NULL
which	NULL
had	NULL
a	NULL
fragment	NULL
of	NULL
approximately	NULL
3	NULL
kb	NULL
,	NULL
were	NULL
identified	NULL
as	NULL
encoding	NULL
the	NULL
new	NULL
member	NULL
,	NULL
designated	NULL
NFATx4	NULL
.	NULL

Plasmid	NULL
constructions	NULL
NFATx2	NULL
and	NULL
NFATx3	NULL
isoforms	NULL
and	NULL
NFATx1	NULL
deletion	NULL
expression	NULL
plasmids	NULL
were	NULL
constructed	NULL
using	NULL
pME-NFATx	NULL
as	NULL
a	NULL
starting	NULL
plasmid	NULL
.	NULL

pME-NFATx	NULL
is	NULL
expression	NULL
plasmid	NULL
for	NULL
NFATx1	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
SR	NULL
«	NULL
promoter	NULL
in	NULL
vector	NULL
pME18S	NULL
and	NULL
has	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
10	NULL
)	NULL
;	NULL
it	NULL
was	NULL
renamed	NULL
pME-NFATx1	NULL
in	NULL
this	NULL
study	NULL
.	NULL

The	NULL
fragment	NULL
(	NULL
positions	NULL
2044-3152	NULL
according	NULL
to	NULL
the	NULL
sequence	NULL
of	NULL
Masuda	NULL
et	NULL
al	NULL
.	NULL

(	NULL
10	NULL
)	NULL
)	NULL
of	NULL
pME-NFATx1	NULL
was	NULL
replaced	NULL
by	NULL
the	NULL
corresponding	NULL
fragments	NULL
containing	NULL
NFATx2-	NULL
or	NULL
NFATx3-specific	NULL
sequences	NULL
for	NULL
pME-NFATx2	NULL
or	NULL
pME-NFATx3	NULL
.	NULL

For	NULL
the	NULL
construction	NULL
of	NULL
pME-NFATx1ACAA	NULL
,	NULL
pME-NFATx1ACPS	NULL
,	NULL
and	NULL
pME-NFATx1AC	NULL
,	NULL
a	NULL
part	NULL
of	NULL
the	NULL
carboxyl-terminal	NULL
coding	NULL
region	NULL
of	NULL
pME-NFATx1	NULL
was	NULL
deleted	NULL
by	NULL
Af	NULL
!	NULL

III	NULL
(	NULL
position	NULL
3152	NULL
)	NULL
,	NULL
Psfl	NULL
(	NULL
position	NULL
3110	NULL
)	NULL
,	NULL
and	NULL
BsfEII	NULL
(	NULL
position	NULL
2298	NULL
)	NULL
digestion	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
plasmid	NULL
pME-NFATx1ACBA	NULL
was	NULL
made	NULL
by	NULL
deleting	NULL
most	NULL
of	NULL
the	NULL
carboxyl1-terminal	NULL
coding	NULL
region	NULL
of	NULL
NFATx1	NULL
(	NULL
positions	NULL
2298-3152	NULL
)	NULL
using	NULL
BsfEII	NULL
and	NULL
For	NULL
construction	NULL
of	NULL
pME-NFATx1ACBP	NULL
,	NULL
the	NULL
156-bp	NULL
Psfl	NULL
fragment	NULL
(	NULL
positions	NULL
3110-3266	NULL
)	NULL
from	NULL
the	NULL
very	NULL
end	NULL
of	NULL
the	NULL
carboxyl-terminal	NULL
coding	NULL
region	NULL
of	NULL
the	NULL
pME-NFATx1	NULL
was	NULL
ligated	NULL
into	NULL
the	NULL
BsfEII	NULL
site	NULL
on	NULL
the	NULL
pME-NFATx1AC	NULL
.	NULL

pME-NFATx4	NULL
was	NULL
formed	NULL
by	NULL
ligation	NULL
of	NULL
the	NULL
EcoRI	NULL
fragment	NULL
,	NULL
which	NULL
contained	NULL
full-length	NULL
NFATx4	NULL
,	NULL
into	NULL
the	NULL
EcoRI	NULL
site	NULL
of	NULL
pME18S	NULL
.	NULL

Plasmid	NULL
pNFAT72Luc	NULL
was	NULL
constructed	NULL
by	NULL
inserting	NULL
three	NULL
copies	NULL
of	NULL
the	NULL
murine	NULL
IL-2	NULL
promoter	NULL
NFAT	NULL
site	NULL
(	NULL
-290	NULL
to	NULL
-261	NULL
)	NULL
into	NULL
the	NULL
Bg/lI	NULL
site	NULL
of	NULL
the	NULL
pmoIL-2-72Luc	NULL
(	NULL
20	NULL
)	NULL
.	NULL

All	NULL
plasmids	NULL
for	NULL
fusions	NULL
between	NULL
the	NULL
GAL4	NULL
DNA	NULL
binding	NULL
domain	NULL
and	NULL
NFATx1	NULL
were	NULL
constructed	NULL
using	NULL
pM	NULL
in	NULL
the	NULL
TransAct	NULL
Assay	NULL
Kit	NULL
(	NULL
Clontech	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
)	NULL
as	NULL
a	NULL
starting	NULL
plasmid	NULL
.	NULL

For	NULL
construction	NULL
of	NULL
pGAL4-X1BB	NULL
,	NULL
pGALA4-X2BB	NULL
,	NULL
and	NULL
pGALA-XIPP	NULL
,	NULL
the	NULL
BstEII	NULL
fragment	NULL
from	NULL
pME-NFATx1	NULL
or	NULL
-NFATx2	NULL
and	NULL
the	NULL
Psfl	NULL
fragment	NULL
(	NULL
positions	NULL
3110-3226	NULL
)	NULL
from	NULL
pME-NFATx1	NULL
were	NULL
ligated	NULL
into	NULL
the	NULL
Smal	NULL
site	NULL
of	NULL
pM	NULL
,	NULL
respectively	NULL
.	NULL

pGAL4-X1PA	NULL
was	NULL
made	NULL
by	NULL
AffIH	NULL
partial	NULL
digestion	NULL
of	NULL
pGAL4-X1PP	NULL
.	NULL

For	NULL
the	NULL
construction	NULL
of	NULL
pG5Luc	NULL
,	NULL
which	NULL
is	NULL
a	NULL
reporter	NULL
plasmid	NULL
with	NULL
five	NULL
GAL4	NULL
DNA	NULL
binding	NULL
sites	NULL
,	NULL
the	NULL
Pvull	NULL
fragment	NULL
(	NULL
positions	NULL
308-736	NULL
)	NULL
from	NULL
pGSCAT	NULL
in	NULL
the	NULL
Trans	NULL
Act	NULL
assay	NULL
kit	NULL
was	NULL
ligated	NULL
into	NULL
the	NULL
Smal	NULL
site	NULL
of	NULL
pUCOQLuc	NULL
(	NULL
21	NULL
)	NULL
.	NULL

To	NULL
form	NULL
pGAL4-X1WT	NULL
,	NULL
synthesized	NULL
primer	NULL
(	NULL
21-mer	NULL
5'-CCGGAATTCGACATCACTTITTA-3	NULL
'	NULL
)	NULL
and	NULL
template	NULL
(	NULL
54-mer	NULL
5'-TTAT	NULL
CTAGACATGTCTCTCCCAATTATCTCGTTCACATCATCTAAAGTG	NULL
ATGTC-3	NULL
'	NULL
)	NULL
were	NULL
annealed	NULL
and	NULL
filled	NULL
in	NULL
with	NULL
Klenow	NULL
fragment	NULL
.	NULL

After	NULL
digestion	NULL
with	NULL
EcoRI	NULL
and	NULL
Xbeal	NULL
,	NULL
this	NULL
fragment	NULL
was	NULL
ligated	NULL
into	NULL
the	NULL
EcoRI	NULL
Xbal	NULL
site	NULL
of	NULL
pM	NULL
plasmid	NULL
.	NULL

For	NULL
alanine	NULL
substitution	NULL
of	NULL
15-amino	NULL
acid	NULL
frans-activation	NULL
sequence	NULL
(	NULL
pGAL4-X1	NULL
M1~pGAL4-X1	NULL
M10	NULL
)	NULL
,	NULL
mutant	NULL
54-mer	NULL
templates	NULL
were	NULL
used	NULL
,	NULL
which	NULL
contain	NULL
nucleotides	NULL
instead	NULL
of	NULL
wild-type	NULL
nucleotides	NULL
encoding	NULL
one	NULL
of	NULL
15	NULL
amino	NULL
acid	NULL
residues	NULL
.	NULL

DNA	NULL
transfections	NULL
Transfection	NULL
of	NULL
Jurkat	NULL
cells	NULL
or	NULL
293	NULL
cells	NULL
was	NULL
performed	NULL
by	NULL
the	NULL
DEAE-dextran	NULL
method	NULL
(	NULL
22	NULL
)	NULL
or	NULL
the	NULL
calcium	NULL
phosphate	NULL
precipitation	NULL
method	NULL
(	NULL
23	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

Transfection	NULL
efficiency	NULL
was	NULL
monitored	NULL
by	NULL
cotransfection	NULL
of	NULL
pCMV/SEAP	NULL
(	NULL
Tropix	NULL
,	NULL
Bedford	NULL
,	NULL
MA	NULL
)	NULL
for	NULL
Jurkat	NULL
cells	NULL
and	NULL
pBC12/RSV/	NULL
SEAP	NULL
(	NULL
Tropix	NULL
)	NULL
for	NULL
293	NULL
cells	NULL
.	NULL

The	NULL
plasmids	NULL
pCMV/SEAP	NULL
and	NULL
pBC12/RSV/	NULL
SEAP	NULL
contain	NULL
the	NULL
CMV	NULL
promoter/enhancer	NULL
and	NULL
the	NULL
RSV	NULL
long	NULL
terminal	NULL
repeat	NULL
driving	NULL
secreted	NULL
alkaline	NULL
phosphatase	NULL
expression	NULL
,	NULL
respectively	NULL
.	NULL

For	NULL
transfection	NULL
into	NULL
Jurkat	NULL
cells	NULL
,	NULL
1	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
3	NULL
ug	NULL
of	NULL
reporter	NULL
plasmid	NULL
pNFAT72Luc	NULL
,	NULL
3	NULL
pg	NULL
of	NULL
internal	NULL
control	NULL
plasmid	NULL
pCMV/	NULL
SEAP	NULL
,	NULL
and	NULL
6	NULL
ug	NULL
of	NULL
NFATx1	NULL
deletion	NULL
expression	NULL
plasmid	NULL
(	NULL
pME-	NULL
TRANSACTIVATION	NULL
SEQUENCE	NULL
OF	NULL
NFATx1	NULL
NFATx1ACAA	NULL
,	NULL
_	NULL
pME-NFATx1ACPS	NULL
,	NULL
-	NULL
pME-NFATx1AC	NULL
,	NULL
-	NULL
pME-NFATx1ACBA	NULL
,	NULL
or	NULL
pME-NFATx1ACBP	NULL
)	NULL
or	NULL
NFAT	NULL
isoform	NULL
expression	NULL
plasmid	NULL
(	NULL
pME-NFATx1	NULL
,	NULL
pME-NFATx2	NULL
,	NULL
pME-NFAT®3	NULL
,	NULL
or	NULL
NFATx4	NULL
)	NULL
.	NULL

Semiconfluent	NULL
293	NULL
cells	NULL
(	NULL
35-mm	NULL
dish	NULL
)	NULL
were	NULL
transfected	NULL
with	NULL
1	NULL
pg	NULL
of	NULL
reporter	NULL
plasmid	NULL
NFATLuc	NULL
(	NULL
20	NULL
)	NULL
or	NULL
pGSLuc	NULL
,	NULL
0.25	NULL
ug	NULL
of	NULL
internal	NULL
control	NULL
plasmid	NULL
pBC12/RSV/SEAP	NULL
(	NULL
Tropix	NULL
)	NULL
,	NULL
and	NULL
2	NULL
ug	NULL
of	NULL
GAL4	NULL
fusion	NULL
expression	NULL
plasmid	NULL
(	NULL
pGAL4-X1BB	NULL
,	NULL
pGAL4-XI1PP	NULL
,	NULL
pGAL4-XIPA	NULL
,	NULL
pGAL4-X1WT	NULL
,	NULL
or	NULL
pGAL4-X1	NULL
M1~pGAL4-X1	NULL
M10	NULL
)	NULL
or	NULL
NFATx	NULL
isoform	NULL
expression	NULL
plasmid	NULL
.	NULL

The	NULL
transfection	NULL
assay	NULL
was	NULL
repeated	NULL
at	NULL
least	NULL
three	NULL
times	NULL
,	NULL
and	NULL
luciferase	NULL
activity	NULL
was	NULL
normalized	NULL
to	NULL
protein	NULL
mass	NULL
and	NULL
alkaline	NULL
phosphatase	NULL
activity	NULL
.	NULL

RT-PCR	NULL
analysis	NULL
Total	NULL
RNA	NULL
(	NULL
2	NULL
ug	NULL
)	NULL
from	NULL
Jurkat	NULL
cells	NULL
was	NULL
isolated	NULL
using	NULL
an	NULL
RNeasy	NULL
kit	NULL
(	NULL
Qiagen	NULL
,	NULL
Chatsworth	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
RNAs	NULL
(	NULL
0.5	NULL
ug	NULL
)	NULL
from	NULL
thymus	NULL
,	NULL
skeletal	NULL
muscle	NULL
,	NULL
and	NULL
kidney	NULL
were	NULL
purchased	NULL
from	NULL
Clontech	NULL
(	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
RNA	NULL
was	NULL
reverse	NULL
transcribed	NULL
at	NULL
42°C	NULL
,	NULL
using	NULL
the	NULL
Superscript	NULL
preamplifica-tion	NULL
system	NULL
(	NULL
Life	NULL
Technologies	NULL
)	NULL
in	NULL
a	NULL
20-pl	NULL
reaction	NULL
mixture	NULL
as	NULL
described	NULL
by	NULL
the	NULL
manufacturer	NULL
.	NULL

For	NULL
PCR	NULL
amplification	NULL
,	NULL
1	NULL
pl	NULL
of	NULL
the	NULL
cDNA	NULL
synthesis	NULL
mixture	NULL
described	NULL
above	NULL
was	NULL
used	NULL
.	NULL

Primer	NULL
pairs	NULL
used	NULL
for	NULL
RT-PCR	NULL
of	NULL
NFATx	NULL
mRNA	NULL
isoforms	NULL
were	NULL
sense	NULL
20-mer	NULL
P1	NULL
(	NULL
5-CTGGACAGCACT	NULL
CAACTCAA-3	NULL
'	NULL
)	NULL
,	NULL
which	NULL
is	NULL
common	NULL
for	NULL
all	NULL
NFATx	NULL
mRNA	NULL
isoforms	NULL
,	NULL
and	NULL
antisense	NULL
20-mer	NULL
P2	NULL
(	NULL
5-CTGGACATGAGAGCACACTG-3	NULL
'	NULL
)	NULL
,	NULL
P3	NULL
(	NULL
5'-GCCAAAACGTAGGTCTCAAC-3	NULL
'	NULL
)	NULL
,	NULL
or	NULL
P4	NULL
(	NULL
5-TGAACTCCTGACCIT	NULL
GTGAT-3	NULL
'	NULL
)	NULL
,	NULL
which	NULL
are	NULL
specific	NULL
for	NULL
NFATx2	NULL
,	NULL
NFATx3	NULL
,	NULL
and	NULL
NFATx4	NULL
,	NULL
respectively	NULL
.	NULL

An	NULL
antisense	NULL
18-mer	NULL
P5	NULL
(	NULL
5'-CCTTGGGAAACAGAAATC3	NULL
'	NULL
)	NULL
was	NULL
also	NULL
used	NULL
with	NULL
P1	NULL
to	NULL
check	NULL
relative	NULL
expression	NULL
of	NULL
NFATx2	NULL
and	NULL
NFATx3	NULL
to	NULL
NFATx1	NULL
.	NULL

The	NULL
cDNA	NULL
was	NULL
amplified	NULL
for	NULL
30	NULL
cycles	NULL
at	NULL
an	NULL
annealing	NULL
temperature	NULL
of	NULL
55°C	NULL
,	NULL
and	NULL
PCR	NULL
products	NULL
were	NULL
then	NULL
analyzed	NULL
by	NULL
electrophoresis	NULL
on	NULL
3	NULL
%	NULL
NuSieve	NULL
agarose	NULL
gels	NULL
(	NULL
FMC	NULL
Bioproducts	NULL
,	NULL
Rockland	NULL
,	NULL
ME	NULL
)	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
Northern	NULL
(	NULL
RNA	NULL
)	NULL
blots	NULL
of	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
RNA	NULL
from	NULL
different	NULL
human	NULL
tissues	NULL
were	NULL
purchased	NULL
from	NULL
Clontech	NULL
(	NULL
no	NULL
.	NULL

7759-1	NULL
,	NULL
lot	NULL
58630	NULL
,	NULL
and	NULL
no	NULL
.	NULL

7760-1	NULL
,	NULL
lot	NULL
58500	NULL
)	NULL
.	NULL

The	NULL
blots	NULL
contained	NULL
2	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
RNA/lane	NULL
,	NULL
and	NULL
the	NULL
quality	NULL
of	NULL
RNA	NULL
was	NULL
controlled	NULL
by	NULL
the	NULL
manufacturer	NULL
by	NULL
hybridization	NULL
of	NULL
a	NULL
representative	NULL
blot	NULL
for	NULL
each	NULL
lot	NULL
of	NULL
RNA	NULL
with	NULL
a	NULL
human	NULL
B-actin	NULL
control	NULL
probe	NULL
.	NULL

To	NULL
detect	NULL
all	NULL
mRNA	NULL
isoforms	NULL
of	NULL
NFATx	NULL
,	NULL
we	NULL
used	NULL
a	NULL
cDNA	NULL
probe	NULL
spanning	NULL
the	NULL
NFATx	NULL
sequence	NULL
(	NULL
positions	NULL
1156-2614	NULL
)	NULL
(	NULL
10	NULL
)	NULL
.	NULL

For	NULL
the	NULL
NFATx2	NULL
isoform	NULL
,	NULL
a	NULL
243-bp	NULL
DNA	NULL
fragment	NULL
was	NULL
generated	NULL
from	NULL
the	NULL
plasmid	NULL
pME-NFATx2	NULL
by	NULL
PCR	NULL
using	NULL
oligonucleotides	NULL
and	NULL
5-GGCTGCAGTAAGCACTGTTA-3	NULL
'	NULL
for	NULL
the	NULL
sense	NULL
and	NULL
antisense	NULL
prim-ers	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
243-bp	NULL
fragment	NULL
was	NULL
purified	NULL
and	NULL
cloned	NULL
into	NULL
the	NULL
pCRII	NULL
vector	NULL
(	NULL
Invitrogen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
and	NULL
the	NULL
106-bp	NULL
EcoRI-Xbel	NULL
fragment	NULL
was	NULL
used	NULL
for	NULL
the	NULL
NFATx2-specific	NULL
hybridization	NULL
probe	NULL
.	NULL

DNA	NULL
probes	NULL
were	NULL
labeled	NULL
by	NULL
random	NULL
priming	NULL
,	NULL
and	NULL
hybridization	NULL
was	NULL
conducted	NULL
in	NULL
Quick	NULL
Hyb	NULL
Hybridization	NULL
Solution	NULL
(	NULL
Stratagene	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
with	NULL
200	NULL
ug/tal	NULL
salmon	NULL
sperm	NULL
DNA	NULL
at	NULL
68°C	NULL
for	NULL
1.5	NULL
h.	NULL
The	NULL
filter	NULL
was	NULL
washed	NULL
in	NULL
2	NULL
%	NULL
SSC/0.1	NULL
%	NULL
SDS	NULL
at	NULL
room	NULL
temperature	NULL
and	NULL
subsequently	NULL
in	NULL
0.1	NULL
%	NULL
SSC/0.1	NULL
%	NULL
SDS	NULL
at	NULL
60°C	NULL
,	NULL
then	NULL
exposed	NULL
to	NULL
x-ray	NULL
film	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSA	NULL
)	NULL
EMSAs	NULL
were	NULL
conducted	NULL
with	NULL
10-Lg	NULL
protein	NULL
extracts	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
24	NULL
)	NULL
.	NULL

The	NULL
oligonucleotides	NULL
used	NULL
in	NULL
EMSAs	NULL
contained	NULL
the	NULL
following	NULL
sequence	NULL
(	NULL
only	NULL
one	NULL
strand	NULL
is	NULL
shown	NULL
;	NULL
sequence	NULL
overhangs	NULL
are	NULL
in	NULL
lower	NULL
case	NULL
)	NULL
:	NULL
NFAT	NULL
site	NULL
from	NULL
the	NULL
human	NULL
IL-2	NULL
(	NULL
25	NULL
)	NULL
,	NULL
5-gatecGGAGGAAAACT	NULL
GTTCATACAGAAGGCGT-3	NULL
'	NULL
.	NULL

Extracts	NULL
from	NULL
transfected	NULL
COS-7	NULL
cells	NULL
were	NULL
prepared	NULL
,	NULL
and	NULL
fractions	NULL
containing	NULL
purified	NULL
AP-1	NULL
were	NULL
obtained	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Results	NULL
Identification	NULL
of	NULL
an	NULL
essential	NULL
domain	NULL
in	NULL
NFATx1	NULL
carboxyl	NULL
terminus	NULL
for	NULL
its	NULL
transactivation	NULL
activity	NULL
We	NULL
recently	NULL
reported	NULL
domain	NULL
analysis	NULL
of	NULL
NFATx1	NULL
and	NULL
found	NULL
that	NULL
transcriptional	NULL
activation	NULL
mediated	NULL
by	NULL
NFATx1	NULL
was	NULL
significantly	NULL
reduced	NULL
by	NULL
deletion	NULL
of	NULL
the	NULL
carboxyl-terminal	NULL
domain	NULL
(	NULL
16	NULL
)	NULL
.	NULL

This	NULL
observation	NULL
focused	NULL
our	NULL
attention	NULL
on	NULL
the	NULL
carboxyl-terminal	NULL
region	NULL
of	NULL
NFATx1	NULL
in	NULL
terms	NULL
of	NULL
transactivation	NULL
function	NULL
.	NULL

We	NULL
then	NULL
made	NULL
a	NULL
series	NULL
of	NULL
constructs	NULL
deleting	NULL
part	NULL
of	NULL
this	NULL
region	NULL
from	NULL
NFATx1	NULL
and	NULL
checked	NULL
transactivation	NULL
in	NULL
Jurkat	NULL
cells	NULL
by	NULL
measuring	NULL
the	NULL
luciferase	NULL
activity	NULL
of	NULL
the	NULL
extract	NULL
of	NULL
Jurkat	NULL
cells	NULL
that	NULL
was	NULL
cotransfected	NULL
with	NULL
the	NULL
reporter	NULL
plasmid	NULL
pNFAT72Luc	NULL
and	NULL
with	NULL
either	NULL
an	NULL
expression	NULL
plasmid	NULL
of	NULL
the	NULL
deleted	NULL
NFATx1	NULL
carboxyl-terminal	NULL
region	NULL
or	NULL
the	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
A	NULL
1075	NULL
1076	NULL
1	NULL
)	NULL
_	NULL
104	NULL
gortuopyiEr	NULL
tonne	NULL
X1	NULL
ACAA	NULL
1028	NULL
X1	NULL
ACPS	NULL
B	NULL
C3	NULL
ewsenl	NULL
cs	NULL
a	NULL
E	NULL
a	NULL
8	NULL
B	NULL
B	NULL
x1	NULL
ACBP	NULL
7	NULL
I	NULL
f	NULL
I	NULL
I	NULL
|	NULL
760	NULL
I	NULL
x1	NULL
1	NULL
ACBA	NULL
|	NULL
I	NULL
D3	NULL
[	NULL
FIGURE	NULL
1	NULL
.	NULL

Fifteen	NULL
amino	NULL
acid	NULL
residues	NULL
in	NULL
the	NULL
carboxyl-terminal	NULL
region	NULL
of	NULL
NFATx1	NULL
are	NULL
essential	NULL
(	NULL
A	NULL
)	NULL
and	NULL
sufficient	NULL
(	NULL
B	NULL
)	NULL
for	NULL
frans-activation	NULL
activity	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

A	NULL
schematic	NULL
representation	NULL
of	NULL
the	NULL
structure	NULL
of	NULL
NFATx1	NULL
is	NULL
shown	NULL
(	NULL
see	NULL
also	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
3	NULL
ug	NULL
of	NULL
the	NULL
reporter	NULL
plasmid	NULL
pNFAT72Luc	NULL
,	NULL
3	NULL
pg	NULL
of	NULL
the	NULL
internal	NULL
control	NULL
plasmid	NULL
pCMV/SEAP	NULL
,	NULL
and	NULL
6	NULL
ug	NULL
of	NULL
the	NULL
expression	NULL
plasmids	NULL
containing	NULL
several	NULL
deletions	NULL
in	NULL
the	NULL
carboxyl-terminal	NULL
region	NULL
of	NULL
NFATx1	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
PMA	NULL
and	NULL
calcium	NULL
ionophore	NULL
for	NULL
8	NULL
h	NULL
before	NULL
harvesting	NULL
.	NULL

Luciferase	NULL
activity	NULL
values	NULL
,	NULL
given	NULL
in	NULL
relative	NULL
luciferase	NULL
units	NULL
(	NULL
RLU	NULL
)	NULL
,	NULL
were	NULL
normalized	NULL
to	NULL
protein	NULL
mass	NULL
in	NULL
the	NULL
whole	NULL
cell	NULL
lysates	NULL
and	NULL
to	NULL
transfection	NULL
efficiency	NULL
.	NULL

Transfection	NULL
efficiency	NULL
was	NULL
monitored	NULL
by	NULL
measuring	NULL
alkaline	NULL
phosphatase	NULL
activity	NULL
.	NULL

The	NULL
data	NULL
are	NULL
averages	NULL
for	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

empty	NULL
vector	NULL
(	NULL
pME18S	NULL
)	NULL
.	NULL

The	NULL
plasmid	NULL
pCMV/SEAP	NULL
was	NULL
used	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
to	NULL
monitor	NULL
transfection	NULL
efficiency	NULL
.	NULL

The	NULL
transfected	NULL
Jurkat	NULL
cells	NULL
were	NULL
incubated	NULL
at	NULL
37°C	NULL
for	NULL
40	NULL
h	NULL
and	NULL
stimulated	NULL
with	NULL
a	NULL
combination	NULL
of	NULL
PMA	NULL
and	NULL
A23187	NULL
for	NULL
8	NULL
h	NULL
before	NULL
harvest	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
plasmid	NULL
containing	NULL
a	NULL
deletion	NULL
of	NULL
31	NULL
amino	NULL
acids	NULL
from	NULL
the	NULL
end	NULL
of	NULL
NFATx1	NULL
(	NULL
pME-NFATx1ACAA	NULL
)	NULL
still	NULL
conferred	NULL
the	NULL
same	NULL
transactivation	NULL
activity	NULL
as	NULL
the	NULL
full-length	NULL
construct	NULL
of	NULL
NFATx1	NULL
(	NULL
pME-NFATx1	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
the	NULL
expression	NULL
plasmid	NULL
containing	NULL
a	NULL
47-amino	NULL
acid	NULL
deletion	NULL
from	NULL
the	NULL
end	NULL
of	NULL
NFATx1	NULL
(	NULL
pME-NFATx1ACPS	NULL
)	NULL
showed	NULL
a	NULL
severely	NULL
decreased	NULL
transactivation	NULL
activity	NULL
compared	NULL
with	NULL
pME-NFATx1	NULL
.	NULL

These	NULL
results	NULL
clearly	NULL
indicated	NULL
that	NULL
the	NULL
16-amino	NULL
acid	NULL
sequence	NULL
of	NULL
NFATx1	NULL
(	NULL
QDITLDDVNEIIGRDM	NULL
)	NULL
were	NULL
important	NULL
for	NULL
transactivation	NULL
activity	NULL
mediated	NULL
by	NULL
NFATx1	NULL
.	NULL

To	NULL
prove	NULL
that	NULL
these	NULL
amino	NULL
acid	NULL
residues	NULL
in	NULL
the	NULL
NFATx1	NULL
carboxyl	NULL
terminus	NULL
were	NULL
sufficient	NULL
for	NULL
its	NULL
transactivation	NULL
activity	NULL
,	NULL
we	NULL
checked	NULL
the	NULL
transactivation	NULL
activities	NULL
of	NULL
different	NULL
deletion	NULL
constructs	NULL
lacking	NULL
other	NULL
parts	NULL
of	NULL
the	NULL
carboxyl	NULL
terminus	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
1B	NULL
,	NULL
the	NULL
expression	NULL
construct	NULL
pME-NFATx1AC	NULL
,	NULL
which	NULL
had	NULL
most	NULL
of	NULL
the	NULL
carboxyl-terminal	NULL
domain	NULL
of	NULL
NFATx1	NULL
deleted	NULL
,	NULL
conferred	NULL
no	NULL
increase	NULL
in	NULL
transactivation	NULL
activity	NULL
.	NULL

Interestingly	NULL
,	NULL
transfection	NULL
of	NULL
the	NULL
expression	NULL
plasmid	NULL
pME-NFATx1ACBP	NULL
,	NULL
containing	NULL
this	NULL
deletion	NULL
fused	NULL
with	NULL
the	NULL
end	NULL
of	NULL
the	NULL
carboxyl-terminal	NULL
region	NULL
,	NULL
3457	NULL
including	NULL
the	NULL
15-amino	NULL
acid	NULL
sequence	NULL
(	NULL
DITLDDVNEIIGRDM	NULL
)	NULL
that	NULL
we	NULL
had	NULL
identified	NULL
,	NULL
resulted	NULL
in	NULL
the	NULL
same	NULL
level	NULL
of	NULL
increased	NULL
activity	NULL
as	NULL
pME-NFATx1	NULL
.	NULL

However	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
previous	NULL
results	NULL
,	NULL
the	NULL
expression	NULL
plasmid	NULL
pME-NFATx1ACBA	NULL
containing	NULL
this	NULL
large	NULL
deletion	NULL
fused	NULL
with	NULL
the	NULL
end	NULL
of	NULL
that	NULL
carboxyl	NULL
terminus	NULL
that	NULL
lacked	NULL
the	NULL
15-amino	NULL
acid	NULL
sequence	NULL
conferred	NULL
no	NULL
increase	NULL
in	NULL
activity	NULL
.	NULL

From	NULL
these	NULL
results	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
the	NULL
carboxyl-terminal	NULL
region	NULL
of	NULL
NFATx1	NULL
has	NULL
a	NULL
role	NULL
in	NULL
its	NULL
transactivation	NULL
activity	NULL
and	NULL
that	NULL
a	NULL
sequence	NULL
,	NULL
consisting	NULL
of	NULL
the	NULL
15-amino	NULL
acid	NULL
sequence	NULL
(	NULL
DITLDD	NULL
VNEIGRDM	NULL
)	NULL
,	NULL
is	NULL
essential	NULL
and	NULL
apparently	NULL
sufficient	NULL
for	NULL
the	NULL
transactivation	NULL
activity	NULL
mediated	NULL
by	NULL
NFATx1	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

The	NULL
results	NULL
also	NULL
indicate	NULL
that	NULL
other	NULL
sequences	NULL
in	NULL
the	NULL
carboxyl	NULL
terminus	NULL
of	NULL
NFATx1	NULL
can	NULL
be	NULL
deleted	NULL
without	NULL
detrimental	NULL
effects	NULL
on	NULL
its	NULL
transactivation	NULL
activity	NULL
as	NULL
measured	NULL
in	NULL
our	NULL
assays	NULL
.	NULL

Transactivation	NULL
sequence	NULL
of	NULL
NFATx1	NULL
To	NULL
assess	NULL
whether	NULL
the	NULL
15	NULL
amino	NULL
acid	NULL
residues	NULL
of	NULL
NFATx1	NULL
we	NULL
identified	NULL
had	NULL
any	NULL
intrinsic	NULL
transactivation	NULL
potential	NULL
,	NULL
chimeric	NULL
molecules	NULL
were	NULL
generated	NULL
by	NULL
fusing	NULL
portions	NULL
of	NULL
the	NULL
NFATx1	NULL
carboxyl-terminal	NULL
sequence	NULL
to	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
GALA	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

These	NULL
constructs	NULL
were	NULL
assayed	NULL
for	NULL
their	NULL
ability	NULL
to	NULL
transactivate	NULL
reporters	NULL
driven	NULL
by	NULL
GAL4	NULL
DNA	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
human	NULL
embryonic	NULL
kidney	NULL
HEK	NULL
293	NULL
cells	NULL
.	NULL

We	NULL
included	NULL
a	NULL
pM	NULL
vector	NULL
that	NULL
encodes	NULL
only	NULL
the	NULL
GAL4	NULL
DNA	NULL
binding	NULL
domain	NULL
as	NULL
a	NULL
negative	NULL
control	NULL
.	NULL

The	NULL
results	NULL
showed	NULL
that	NULL
the	NULL
entire	NULL
carboxyl-terminal	NULL
region	NULL
of	NULL
NFATx1	NULL
(	NULL
amino	NULL
acids	NULL
761-1075	NULL
)	NULL
was	NULL
sufficient	NULL
for	NULL
transcriptional	NULL
activation	NULL
(	NULL
X1BB	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
46-amino	NULL
acid	NULL
residues	NULL
from	NULL
the	NULL
very	NULL
end	NULL
of	NULL
the	NULL
carboxyl	NULL
terminus	NULL
of	NULL
NFATx1	NULL
(	NULL
amino	NULL
acids	NULL
1030-1075	NULL
)	NULL
and	NULL
15-amino	NULL
acid	NULL
residues	NULL
(	NULL
amino	NULL
acids	NULL
1030-1044	NULL
)	NULL
were	NULL
also	NULL
found	NULL
to	NULL
activate	NULL
transcription	NULL
just	NULL
as	NULL
efficiently	NULL
as	NULL
the	NULL
whole	NULL
carboxyl-terminal	NULL
region	NULL
of	NULL
NFATx1	NULL
did	NULL
(	NULL
X1PP	NULL
and	NULL
X1PA	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
sequence	NULL
,	NULL
consisting	NULL
of	NULL
15	NULL
amino	NULL
acids	NULL
from	NULL
the	NULL
carboxyl	NULL
terminus	NULL
of	NULL
NFATx1	NULL
,	NULL
was	NULL
an	NULL
intrinsic	NULL
transactivation	NULL
sequence	NULL
.	NULL

We	NULL
further	NULL
investigated	NULL
this	NULL
15-amino	NULL
acid	NULL
transactivation	NULL
sequence	NULL
using	NULL
a	NULL
series	NULL
of	NULL
mutants	NULL
that	NULL
have	NULL
one	NULL
amino	NULL
acid	NULL
substitution	NULL
to	NULL
alanine	NULL
from	NULL
the	NULL
X1PA	NULL
GAL4	NULL
fusion	NULL
protein	NULL
.	NULL

These	NULL
mutation	NULL
constructs	NULL
were	NULL
assayed	NULL
for	NULL
their	NULL
ability	NULL
using	NULL
transient	NULL
transfection	NULL
as	NULL
described	NULL
above	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
2B	NULL
,	NULL
most	NULL
of	NULL
the	NULL
amino	NULL
acid	NULL
residues	NULL
we	NULL
substituted	NULL
,	NULL
except	NULL
asparagine	NULL
(	NULL
M5	NULL
)	NULL
,	NULL
were	NULL
critical	NULL
for	NULL
the	NULL
potential	NULL
as	NULL
a	NULL
transactivation	NULL
sequence	NULL
.	NULL

Notably	NULL
,	NULL
the	NULL
mutation	NULL
on	NULL
the	NULL
hydrophobic	NULL
residue	NULL
(	NULL
leucine	NULL
,	NULL
valine	NULL
,	NULL
or	NULL
isoleucine	NULL
)	NULL
completely	NULL
abrogated	NULL
the	NULL
intrinsic	NULL
transactivation	NULL
potential	NULL
(	NULL
M1	NULL
,	NULL
M4	NULL
,	NULL
M7	NULL
,	NULL
and	NULL
M8	NULL
)	NULL
.	NULL

Isolation	NULL
of	NULL
mRNA	NULL
isoforms	NULL
for	NULL
NFAT	NULL
We	NULL
previously	NULL
reported	NULL
the	NULL
cloning	NULL
of	NULL
NFATx1	NULL
,	NULL
a	NULL
member	NULL
of	NULL
the	NULL
NFAT	NULL
family	NULL
(	NULL
10	NULL
)	NULL
.	NULL

During	NULL
further	NULL
screening	NULL
for	NULL
NFAT	NULL
cDNA	NULL
clones	NULL
from	NULL
the	NULL
Jurkat	NULL
cDNA	NULL
library	NULL
,	NULL
we	NULL
isolated	NULL
two	NULL
additional	NULL
isoforms	NULL
of	NULL
NFATx	NULL
,	NULL
designated	NULL
NFATx2	NULL
and	NULL
NFATx3	NULL
.	NULL

These	NULL
two	NULL
clones	NULL
had	NULL
distinct	NULL
104-	NULL
and	NULL
89-bp	NULL
insertion	NULL
sequences	NULL
at	NULL
the	NULL
same	NULL
position	NULL
,	NULL
position	NULL
3131	NULL
according	NULL
to	NULL
the	NULL
sequence	NULL
of	NULL
Masuda	NULL
et	NULL
al	NULL
.	NULL

(	NULL
10	NULL
)	NULL
,	NULL
in	NULL
the	NULL
3'-coding	NULL
region	NULL
of	NULL
the	NULL
NFATx1	NULL
cDNA	NULL
sequence	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

The	NULL
insertions	NULL
,	NULL
displaying	NULL
no	NULL
homology	NULL
to	NULL
sequence	NULL
in	NULL
NFATx1	NULL
or	NULL
to	NULL
any	NULL
other	NULL
sequence	NULL
in	NULL
the	NULL
available	NULL
databases	NULL
,	NULL
resulted	NULL
in	NULL
a	NULL
frame	NULL
shift	NULL
and	NULL
replacement	NULL
of	NULL
the	NULL
most	NULL
carboxyl-terminal	NULL
40	NULL
residues	NULL
of	NULL
the	NULL
NFATx1	NULL
by	NULL
33	NULL
and	NULL
30	NULL
unrelated	NULL
amino	NULL
acids	NULL
for	NULL
NFATx2	NULL
and	NULL
NFATx3	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
B	NULL
and	NULL
C	NULL
)	NULL
.	NULL

We	NULL
also	NULL
screened	NULL
a	NULL
cDNA	NULL
library	NULL
obtained	NULL
from	NULL
T	NULL
Ag-transformed	NULL
human	NULL
diploid	NULL
fibroblast	NULL
and	NULL
isolated	NULL
another	NULL
NFATx	NULL
cDNA	NULL
,	NULL
designated	NULL
NFATx4	NULL
.	NULL

Similar	NULL
to	NULL
the	NULL
other	NULL
isoforms	NULL
,	NULL
the	NULL
NFATx4	NULL
sequence	NULL
was	NULL
identical	NULL
up	NULL
to	NULL
nucleotide	NULL
position	NULL
3131	NULL
with	NULL
the	NULL
other	NULL
isoforms	NULL
,	NULL
and	NULL
the	NULL
last	NULL
40	NULL
amino	NULL
acid	NULL
residues	NULL
of	NULL
NFATx1	NULL
were	NULL
also	NULL
replaced	NULL
by	NULL
10	NULL
unrelated	NULL
amino	NULL
acids	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
3458	NULL
A	NULL
RLU	NULL
0.8	NULL
GAL4DBD	NULL
Xx1BB	NULL
(	NULL
761-1075	NULL
)	NULL
X1PP	NULL
(	NULL
1030-1075	NULL
)	NULL
X1PA	NULL
(	NULL
1030-1044	NULL
)	NULL
0.8	NULL
GAL4DBD	NULL
wT	NULL
M1	NULL
M2	NULL
Ms	NULL
M4	NULL
Ms	NULL
Mo	NULL
M7	NULL
MB	NULL
mg	NULL
M10	NULL
FIGURE	NULL
2	NULL
.	NULL

The	NULL
transactivation	NULL
sequence	NULL
of	NULL
NFATx1	NULL
(	NULL
4	NULL
)	NULL
and	NULL
the	NULL
effect	NULL
of	NULL
mutation	NULL
(	NULL
B	NULL
)	NULL
.	NULL

The	NULL
NFATx1	NULL
transactivation	NULL
sequence	NULL
(	NULL
WT	NULL
)	NULL
and	NULL
the	NULL
mutant	NULL
sequence	NULL
with	NULL
individual	NULL
substitutions	NULL
(	NULL
M1	NULL
~	NULL
M10	NULL
)	NULL
are	NULL
shown	NULL
.	NULL

293	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
1	NULL
pg	NULL
of	NULL
the	NULL
reporter	NULL
plasmid	NULL
pGSLuc	NULL
,	NULL
0.25	NULL
ug	NULL
of	NULL
the	NULL
internal	NULL
control	NULL
plasmid	NULL
pBC12/RSV/SEAP	NULL
,	NULL
and	NULL
2	NULL
ug	NULL
of	NULL
the	NULL
expression	NULL
plasmid	NULL
for	NULL
GAL4	NULL
fusion	NULL
protein	NULL
(	NULL
pM	NULL
[	NULL
GAL4DBD	NULL
]	NULL
,	NULL
pGAL4-X1BB	NULL
,	NULL
pGAL4-XIPP	NULL
,	NULL
pGAL4-XIPA	NULL
,	NULL
pGALA4-X1WT	NULL
,	NULL
or	NULL
pGAL4-X1	NULL
M1~-X1	NULL
M10	NULL
)	NULL
,	NULL
and	NULL
assayed	NULL
for	NULL
luciferase	NULL
activity	NULL
48	NULL
h	NULL
later	NULL
.	NULL

Luciferase	NULL
activity	NULL
was	NULL
assayed	NULL
described	NULL
in	NULL
Figure	NULL
1	NULL
.	NULL

The	NULL
data	NULL
are	NULL
averages	NULL
for	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

A-C	NULL
)	NULL
.	NULL

Nucleotide	NULL
sequences	NULL
were	NULL
deposited	NULL
in	NULL
the	NULL
GenBank	NULL
sequence	NULL
databank	NULL
and	NULL
are	NULL
not	NULL
shown	NULL
here	NULL
.	NULL

In	NULL
short	NULL
,	NULL
we	NULL
found	NULL
four	NULL
distinct	NULL
cDNA	NULL
clones	NULL
of	NULL
NFAT	NULL
'	NULL
x	NULL
,	NULL
designated	NULL
NFATx1	NULL
,	NULL
NFATx2	NULL
,	NULL
NFATx3	NULL
,	NULL
and	NULL
NFATx4	NULL
,	NULL
which	NULL
are	NULL
most	NULL
likely	NULL
derived	NULL
by	NULL
alternative	NULL
splicing	NULL
at	NULL
a	NULL
common	NULL
site	NULL
in	NULL
the	NULL
coding	NULL
sequence	NULL
.	NULL

The	NULL
absence	NULL
of	NULL
a	NULL
consensus	NULL
splice	NULL
donor	NULL
and	NULL
acceptor	NULL
sequences	NULL
at	NULL
the	NULL
junctions	NULL
(	NULL
position	NULL
3131	NULL
)	NULL
makes	NULL
it	NULL
unlikely	NULL
that	NULL
these	NULL
isoforms	NULL
represent	NULL
incompletely	NULL
spliced	NULL
transcripts	NULL
and	NULL
likely	NULL
that	NULL
alternative	NULL
ex-ons	NULL
were	NULL
used	NULL
for	NULL
these	NULL
isoforms	NULL
.	NULL

Verification	NULL
of	NULL
this	NULL
hypothesis	NULL
,	NULL
however	NULL
,	NULL
awaits	NULL
deciphering	NULL
of	NULL
the	NULL
precise	NULL
exonic	NULL
structure	NULL
of	NULL
the	NULL
NFATx	NULL
gene	NULL
.	NULL

Most	NULL
interestingly	NULL
,	NULL
junctions	NULL
for	NULL
these	NULL
isoforms	NULL
are	NULL
located	NULL
in	NULL
the	NULL
15-amino	NULL
acid	NULL
transactivation	NULL
sequence	NULL
that	NULL
we	NULL
identified	NULL
in	NULL
the	NULL
NFATx1	NULL
.	NULL

Consequently	NULL
,	NULL
these	NULL
three	NULL
isoforms	NULL
have	NULL
different	NULL
corresponding	NULL
sequences	NULL
to	NULL
the	NULL
transactivation	NULL
sequence	NULL
of	NULL
NFATx1	NULL
.	NULL

Starting	NULL
from	NULL
the	NULL
first	NULL
ATG	NULL
codon	NULL
,	NULL
NFATx1	NULL
has	NULL
TRANSACTIVATION	NULL
SEQUENCE	NULL
OF	NULL
NFATx1	NULL
A	NULL
Pi	NULL
Ps	NULL
-	NULL
»	NULL
<	NULL
-1	NULL
a131	NULL
¥	NULL
/	NULL
l/	NULL
|	NULL
polyA	NULL
]	NULL
NFATx1	NULL
T	NULL
al	NULL
|	NULL
po	NULL
ps	NULL
-	NULL
»	NULL
|	NULL
-_	NULL
<	NULL
-	NULL
<	NULL
-fa	NULL
I	NULL
¥	NULL
/	NULL
[	NULL
»	NULL
ECH	NULL
polyA	NULL
|	NULL
NFATx2	NULL
/	NULL
I	NULL
Pi	NULL
Po	NULL
Ps	NULL
I	NULL
1	NULL
%	NULL
;	NULL
<	NULL
-	NULL
'	NULL
<	NULL
-//	NULL
[	NULL
s=	NULL
|	NULL
Z	NULL
I	NULL
1	NULL
1	NULL
1	NULL
v	NULL
<	NULL
-	NULL
/	NULL
\\	NULL
:	NULL
B	NULL
polyA	NULL
|	NULL
NFATx3	NULL
pa	NULL
1035	NULL
1	NULL
408	NULL
674	NULL
¢	NULL
I	NULL
NFATx2	NULL
[	NULL
|	NULL
[	NULL
J	NULL
,	NULL
18	NULL
NFATx3	NULL
[	NULL
|	NULL
M|	NULL
¢	NULL
1045	NULL
NFATx4	NULL
[	NULL
J	NULL
n	NULL
Jr	NULL
]	NULL
_	NULL
Ret	NULL
comein	NULL
|	NULL
--	NULL
%	NULL
1065	NULL
t	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
1022	NULL
1076	NULL
v	NULL
+	NULL
+++	NULL
«	NULL
TLODVNET	NULL
IGRDMSOT	NULL
SVSQGAGVSROAPLRSPESLOLGRSDGL	NULL
NFATx1	NULL
v	NULL
toss	NULL
*+	NULL
++	NULL
®	NULL
NFATx2	NULL
M	NULL
1055	NULL
«	NULL
+++	NULL
«	NULL
NFATIGLODITLODDLPTSNNFDLLOLRPTEWPVPACRYLRNLE	NULL
NFATx3	NULL
v	NULL
tors	NULL
**+**	NULL
NEATIGLODITLODGEFISDNEL	NULL
NFATx4	NULL
FIGURE	NULL
3	NULL
.	NULL

A	NULL
,	NULL
Schematic	NULL
drawing	NULL
of	NULL
the	NULL
3	NULL
'	NULL
region	NULL
of	NULL
NFAT	NULL
isoform	NULL
cDNAs	NULL
.	NULL

Arrowheads	NULL
indicate	NULL
stop	NULL
codons	NULL
.	NULL

The	NULL
arrows	NULL
indicate	NULL
primers	NULL
used	NULL
for	NULL
RT-PCR	NULL
,	NULL
pointing	NULL
in	NULL
the	NULL
direction	NULL
of	NULL
polymerase	NULL
reaction	NULL
,	NULL
and	NULL
the	NULL
primers	NULL
are	NULL
numbered	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

B	NULL
,	NULL
Schematic	NULL
representation	NULL
of	NULL
the	NULL
structure	NULL
of	NULL
NFATx	NULL
isoforms	NULL
.	NULL

Rel	NULL
similarity	NULL
domains	NULL
are	NULL
indicated	NULL
.	NULL

SP	NULL
boxes	NULL
are	NULL
represented	NULL
by	NULL
small	NULL
rectangles	NULL
.	NULL

The	NULL
specific	NULL
carboxyl-terminal	NULL
region	NULL
of	NULL
each	NULL
isoform	NULL
is	NULL
indicated	NULL
.	NULL

The	NULL
arrow	NULL
at	NULL
amino	NULL
acid	NULL
1035	NULL
(	NULL
nucleotide	NULL
position	NULL
3131	NULL
)	NULL
indicates	NULL
the	NULL
common	NULL
insertion	NULL
site	NULL
.	NULL

B	NULL
,	NULL
Amino	NULL
acid	NULL
sequences	NULL
of	NULL
the	NULL
carboxyl-terminal	NULL
end	NULL
of	NULL
NFATx	NULL
isoforms	NULL
,	NULL
NFATx1	NULL
,	NULL
NFATx2	NULL
,	NULL
NFATx3	NULL
,	NULL
and	NULL
NFATx4	NULL
.	NULL

Most	NULL
carboxyl-terminal	NULL
40	NULL
amino	NULL
acids	NULL
of	NULL
NFATx1	NULL
are	NULL
replaced	NULL
by	NULL
distinct	NULL
amino	NULL
acids	NULL
for	NULL
each	NULL
isoform	NULL
.	NULL

The	NULL
arrowhead	NULL
above	NULL
the	NULL
sequence	NULL
indicates	NULL
the	NULL
common	NULL
insertion	NULL
site	NULL
of	NULL
x1	NULL
,	NULL
x2	NULL
,	NULL
x3	NULL
,	NULL
and	NULL
x4	NULL
isoforms	NULL
.	NULL

The	NULL
transactivation	NULL
sequence	NULL
of	NULL
NFATx1	NULL
is	NULL
underlined	NULL
.	NULL

NFATx2	NULL
,	NULL
NFATx3	NULL
,	NULL
and	NULL
NFATx4	NULL
have	NULL
a	NULL
part	NULL
of	NULL
this	NULL
transactivation	NULL
sequence	NULL
(	NULL
thin	NULL
underline	NULL
)	NULL
.	NULL

The	NULL
cDNA	NULL
sequences	NULL
of	NULL
NFATx2	NULL
,	NULL
NFATx3	NULL
,	NULL
and	NULL
NFATx4	NULL
have	NULL
been	NULL
submitted	NULL
to	NULL
GenBank	NULL
(	NULL
accession	NULL
nos	NULL
.	NULL

U85428	NULL
,	NULL
U85429	NULL
,	NULL
and	NULL
U85430	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

1,075	NULL
amino	NULL
acid	NULL
residues	NULL
,	NULL
NFATx2	NULL
has	NULL
1,068	NULL
residues	NULL
,	NULL
NFATx3	NULL
has	NULL
1,065	NULL
residues	NULL
,	NULL
and	NULL
NFAT	NULL
x4	NULL
has	NULL
1045	NULL
residues	NULL
,	NULL
with	NULL
predicted	NULL
molecular	NULL
masses	NULL
of	NULL
115,592	NULL
,	NULL
115,310	NULL
,	NULL
115,124	NULL
,	NULL
and	NULL
112,625	NULL
Da	NULL
,	NULL
respectively	NULL
,	NULL
and	NULL
they	NULL
differ	NULL
after	NULL
amino	NULL
acid	NULL
residue	NULL
1035	NULL
.	NULL

Tissue	NULL
distribution	NULL
of	NULL
NFATx	NULL
mRNA	NULL
isoforms	NULL
Our	NULL
previous	NULL
report	NULL
showed	NULL
preferential	NULL
expression	NULL
of	NULL
NFAT	NULL
'	NULL
x	NULL
in	NULL
thymus	NULL
and	NULL
leukocytes	NULL
(	NULL
10	NULL
)	NULL
.	NULL

However	NULL
,	NULL
we	NULL
noticed	NULL
that	NULL
when	NULL
we	NULL
used	NULL
a	NULL
newly	NULL
designed	NULL
cDNA	NULL
probe	NULL
(	NULL
positions	NULL
1156-2614	NULL
in	NULL
the	NULL
NFATx1	NULL
sequence	NULL
)	NULL
that	NULL
should	NULL
hybridize	NULL
to	NULL
all	NULL
four	NULL
isoforms	NULL
of	NULL
NFATx	NULL
,	NULL
we	NULL
could	NULL
also	NULL
find	NULL
a	NULL
reasonable	NULL
hybridizing	NULL
band	NULL
with	NULL
an	NULL
apparent	NULL
size	NULL
of	NULL
7.0	NULL
kb	NULL
in	NULL
RNA	NULL
from	NULL
testis	NULL
,	NULL
ovary	NULL
,	NULL
skeletal	NULL
muscle	NULL
,	NULL
and	NULL
kidney	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
.	NULL

This	NULL
result	NULL
suggested	NULL
that	NULL
our	NULL
previously	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
FIGURE	NULL
4	NULL
.	NULL

A	NULL
and	NULL
D	NULL
,	NULL
Expression	NULL
of	NULL
NFATx	NULL
A	NULL
o	NULL
mRNA	NULL
isoforms	NULL
in	NULL
different	NULL
human	NULL
tissues	NULL
.	NULL

Northern	NULL
5	NULL
blots	NULL
were	NULL
hybridized	NULL
with	NULL
cDNA	NULL
probes	NULL
whose	NULL
se-	NULL
a	NULL
o	NULL
43	NULL
quence	NULL
was	NULL
common	NULL
in	NULL
all	NULL
four	NULL
NFATx	NULL
isoforms	NULL
(	NULL
4	NULL
)	NULL
5	NULL
E.	NULL
§	NULL
£	NULL
E	NULL
;	NULL
or	NULL
was	NULL
sequence	NULL
specific	NULL
to	NULL
NFATx2	NULL
(	NULL
D	NULL
)	NULL
.	NULL

That	NULL
an	NULL
g-ﬁ	NULL
g	NULL
E	NULL
3	NULL
E	NULL
equal	NULL
amount	NULL
of	NULL
RNA	NULL
was	NULL
loaded	NULL
in	NULL
each	NULL
lane	NULL
was	NULL
ie	NULL
verified	NULL
by	NULL
hybridization	NULL
with	NULL
a	NULL
B-actin	NULL
probe	NULL
(	NULL
data	NULL
3-2	NULL
:	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
size	NULL
markers	NULL
are	NULL
indi-	NULL
34	NULL
--	NULL
'	NULL
E	NULL
,	NULL
cated	NULL
on	NULL
the	NULL
left	NULL
.	NULL

B	NULL
and	NULL
C	NULL
,	NULL
RT-PCR	NULL
analysis	NULL
of	NULL
NFATx	NULL
mRNA	NULL
isoforms	NULL
in	NULL
Jurkat	NULL
cells	NULL
and	NULL
human	NULL
tissues	NULL
.	NULL

The	NULL
amplified	NULL
DNAs	NULL
were	NULL
analyzed	NULL
on	NULL
a	NULL
3	NULL
%	NULL
NuSieve-agarose	NULL
gel	NULL
.	NULL

The	NULL
gel	NULL
stained	NULL
with	NULL
ethidium	NULL
bromide	NULL
was	NULL
photographed	NULL
.	NULL

B	NULL
,	NULL
The	NULL
specific	NULL
segment	NULL
of	NULL
NFATx	NULL
mRNA	NULL
isoforms	NULL
was	NULL
amplified	NULL
using	NULL
a	NULL
B	NULL
primer	NULL
pair	NULL
in	NULL
which	NULL
one	NULL
primer	NULL
contained	NULL
NFATx2-	NULL
,	NULL
NFATx3-	NULL
,	NULL
or	NULL
NFATx4-specific	NULL
sequence	NULL
(	NULL
see	NULL
also	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
:	NULL
P1	NULL
and	NULL
P2	NULL
for	NULL
NFATx2	NULL
(	NULL
276	NULL
bp	NULL
)	NULL
,	NULL
P1	NULL
and	NULL
P3	NULL
for	NULL
NFATx3	NULL
(	NULL
249	NULL
bp	NULL
)	NULL
,	NULL
and	NULL
P1	NULL
and	NULL
P4	NULL
for	NULL
NFATx4	NULL
(	NULL
425	NULL
bp	NULL
)	NULL
.	NULL

Lane	NULL
1	NULL
represents	NULL
a	NULL
digest	NULL
of	NULL
$	NULL
X174	NULL
DNA	NULL
with	NULL
Haelll	NULL
as	NULL
a	NULL
size	NULL
marker	NULL
.	NULL

For	NULL
a	NULL
control	NULL
,	NULL
expression	NULL
plasmids	NULL
of	NULL
pME-NFATx1	NULL
,	NULL
pME-NFATx2	NULL
,	NULL
pME-NFATx3	NULL
,	NULL
and	NULL
pME-NFATx4	NULL
were	NULL
also	NULL
amplified	NULL
with	NULL
each	NULL
primer	NULL
set	NULL
(	NULL
lane	NULL
2-5	NULL
)	NULL
.	NULL

C	NULL
,	NULL
Comparison	NULL
of	NULL
relative	NULL
expression	NULL
levels	NULL
of	NULL
NFATx	NULL
mRNA	NULL
isoforms	NULL
in	NULL
human	NULL
tissues	NULL
using	NULL
a	NULL
primer	NULL
pair	NULL
(	NULL
P1	NULL
and	NULL
P5	NULL
)	NULL
amplifying	NULL
a	NULL
region	NULL
that	NULL
contained	NULL
the	NULL
common	NULL
insertion	NULL
site	NULL
in	NULL
the	NULL
3'-coding	NULL
region	NULL
of	NULL
NFATx	NULL
.	NULL

This	NULL
primer	NULL
pair	NULL
amplifies	NULL
NFATx1-	NULL
,	NULL
NFATx2~	NULL
,	NULL
and	NULL
NFATx3-specific	NULL
segments	NULL
simultaneously	NULL
.	NULL

Lanes	NULL
7	NULL
and	NULL
5	NULL
represent	NULL
a	NULL
digest	NULL
of	NULL
$	NULL
X174	NULL
DNA	NULL
with	NULL
HaellI	NULL
as	NULL
a	NULL
size	NULL
marker	NULL
.	NULL

Reaction	NULL
without	NULL
RT	NULL
(	NULL
Zanes	NULL
3	NULL
,	NULL
7	NULL
,	NULL
10	NULL
,	NULL
and	NULL
13	NULL
)	NULL
or	NULL
RNA	NULL
(	NULL
lanes	NULL
4	NULL
,	NULL
8	NULL
,	NULL
11	NULL
,	NULL
and	NULL
14	NULL
)	NULL
is	NULL
indicated	NULL
.	NULL

m	NULL
m	NULL
I	NULL
1.4-	NULL
NFATx1	NULL
NFATx2	NULL
NFATx3	NULL
reported	NULL
expression	NULL
profile	NULL
was	NULL
specific	NULL
to	NULL
the	NULL
NFATx1	NULL
isoform	NULL
and	NULL
that	NULL
the	NULL
tissue	NULL
distributions	NULL
of	NULL
the	NULL
other	NULL
NFAT	NULL
'	NULL
x	NULL
isoforms	NULL
were	NULL
distinct	NULL
.	NULL

To	NULL
confirm	NULL
the	NULL
above	NULL
observation	NULL
,	NULL
we	NULL
performed	NULL
an	NULL
RT-PCR	NULL
analysis	NULL
that	NULL
distinguished	NULL
the	NULL
newly	NULL
isolated	NULL
isoforms	NULL
by	NULL
the	NULL
size	NULL
of	NULL
the	NULL
resulting	NULL
PCR	NULL
product	NULL
.	NULL

To	NULL
amplify	NULL
a	NULL
specific	NULL
segment	NULL
of	NULL
each	NULL
NFAT	NULL
'	NULL
x	NULL
isoform	NULL
,	NULL
we	NULL
used	NULL
a	NULL
primer	NULL
pair	NULL
in	NULL
which	NULL
one	NULL
primer	NULL
contained	NULL
an	NULL
NFATx2-	NULL
,	NULL
NFATx3-	NULL
,	NULL
or	NULL
NFAT	NULL
sequence	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

We	NULL
did	NULL
amplify	NULL
a	NULL
specific	NULL
segment	NULL
of	NULL
NFATx2	NULL
or	NULL
NFATx3	NULL
,	NULL
but	NULL
not	NULL
of	NULL
NFATx4	NULL
,	NULL
using	NULL
total	NULL
RNA	NULL
from	NULL
Jurkat	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

This	NULL
result	NULL
indicated	NULL
that	NULL
both	NULL
NFATx2	NULL
and	NULL
NFATx3	NULL
,	NULL
but	NULL
not	NULL
NFATx4	NULL
mRNA	NULL
,	NULL
were	NULL
expressed	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Since	NULL
we	NULL
are	NULL
interested	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
NFAT	NULL
isoforms	NULL
,	NULL
especially	NULL
in	NULL
skeletal	NULL
muscle	NULL
and	NULL
kidney	NULL
where	NULL
NFATx1	NULL
was	NULL
not	NULL
strongly	NULL
expressed	NULL
,	NULL
we	NULL
next	NULL
checked	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
these	NULL
NFATx	NULL
isoforms	NULL
in	NULL
thymus	NULL
,	NULL
skeletal	NULL
muscle	NULL
,	NULL
and	NULL
kidney	NULL
using	NULL
same	NULL
RT-PCR	NULL
analysis	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
4B	NULL
,	NULL
lanes	NULL
7	NULL
to	NULL
9	NULL
,	NULL
the	NULL
NFATx2	NULL
segment	NULL
was	NULL
detected	NULL
in	NULL
all	NULL
these	NULL
tissues	NULL
.	NULL

The	NULL
NFATx3	NULL
segment	NULL
was	NULL
detected	NULL
in	NULL
thymus	NULL
and	NULL
kidney	NULL
,	NULL
but	NULL
not	NULL
in	NULL
skeletal	NULL
muscle	NULL
.	NULL

The	NULL
NFATx4	NULL
segment	NULL
was	NULL
detected	NULL
in	NULL
thymus	NULL
and	NULL
skeletal	NULL
muscle	NULL
,	NULL
but	NULL
not	NULL
in	NULL
kidney	NULL
.	NULL

These	NULL
results	NULL
suggested	NULL
that	NULL
the	NULL
expression	NULL
patterns	NULL
of	NULL
NFAT	NULL
'	NULL
x	NULL
isoforms	NULL
are	NULL
distinct	NULL
in	NULL
those	NULL
tissues	NULL
.	NULL

To	NULL
compare	NULL
the	NULL
relative	NULL
expression	NULL
levels	NULL
of	NULL
NFATx2	NULL
and	NULL
NFATx3	NULL
mRNA	NULL
to	NULL
that	NULL
of	NULL
NFATx1	NULL
,	NULL
we	NULL
designed	NULL
an	NULL
oligonucleotide	NULL
primer	NULL
pair	NULL
(	NULL
P1	NULL
and	NULL
P5	NULL
)	NULL
amplifying	NULL
a	NULL
region	NULL
that	NULL
contained	NULL
the	NULL
common	NULL
insertion	NULL
site	NULL
in	NULL
the	NULL
3	NULL
'	NULL
coding	NULL
region	NULL
of	NULL
NFAT	NULL
'	NULL
x	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

Contrary	NULL
to	NULL
the	NULL
RT-PCR	NULL
analysis	NULL
described	NULL
above	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
,	NULL
this	NULL
primer	NULL
pair	NULL
should	NULL
amplify	NULL
NFATx1-	NULL
,	NULL
NFATx2-	NULL
,	NULL
and	NULL
NFATx3-specific	NULL
segments	NULL
simultaneously	NULL
.	NULL

The	NULL
results	NULL
using	NULL
total	NULL
RNA	NULL
from	NULL
Jurkat	NULL
cells	NULL
revealed	NULL
two	NULL
amplification	NULL
products	NULL
of	NULL
244	NULL
and	NULL
348	NULL
bp	NULL
,	NULL
which	NULL
corresponded	NULL
to	NULL
NFATx1	NULL
and	NULL
NFATx2	NULL
,	NULL
re	NULL
Leukocyte	NULL
Colon	NULL
Thymus	NULL
«	NULL
ae	NULL
NFATx4	NULL
Jurkat	NULL
3459	NULL
C	NULL
Jurkat	NULL
Thymus	NULL
Muscle	NULL
Kidney	NULL
$	NULL
o	NULL
sg	NULL
?	NULL

T	NULL
2	NULL
>	NULL
ts	NULL
0280	NULL
a=	NULL
0	NULL
a	NULL
£	NULL
«	NULL
@	NULL
ss	NULL
$	NULL
05	NULL
ﬂ	NULL
<	NULL
-	NULL
NFATx2	NULL
-	NULL
NFATX1	NULL
12	NULL
340	NULL
506	NULL
7	NULL
80	NULL
91011121314	NULL
8	NULL
z	NULL
D	NULL
2	NULL
85	NULL
3	NULL
o	NULL
As	NULL
0	NULL
{	NULL
0	NULL
<	NULL
;	NULL
8	NULL
5284	NULL
>	NULL
-	NULL
5	NULL
£	NULL
>	NULL
o	NULL
?	NULL

9985	NULL
(	NULL
kb	NULL
)	NULL
<	NULL
-	NULL
NFATx2	NULL
9.5	NULL
78	NULL
4.4	NULL
24	NULL
<	NULL
NFatx3	NULL
_	NULL
``	NULL
*~	NULL
<	NULL
-	NULL
NFATx4	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
spectively	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
lower	NULL
band	NULL
corresponding	NULL
to	NULL
NFATx1	NULL
was	NULL
dominant	NULL
compared	NULL
with	NULL
the	NULL
upper	NULL
band	NULL
,	NULL
which	NULL
corresponded	NULL
to	NULL
NFATx2	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
this	NULL
result	NULL
did	NULL
not	NULL
change	NULL
even	NULL
if	NULL
we	NULL
used	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
or	NULL
total	NULL
RNA	NULL
from	NULL
Jurkat	NULL
cells	NULL
that	NULL
were	NULL
treated	NULL
with	NULL
PMA	NULL
and	NULL
A23187	NULL
for	NULL
3	NULL
h	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Although	NULL
we	NULL
did	NULL
amplify	NULL
an	NULL
NFATx3-specific	NULL
segment	NULL
using	NULL
total	NULL
RNA	NULL
from	NULL
Jurkat	NULL
cells	NULL
by	NULL
RT-PCR	NULL
with	NULL
primer	NULL
pair	NULL
P1	NULL
and	NULL
P3	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
we	NULL
did	NULL
not	NULL
detect	NULL
a	NULL
band	NULL
corresponding	NULL
to	NULL
NFATx3	NULL
(	NULL
333	NULL
bp	NULL
)	NULL
in	NULL
this	NULL
RT-PCR	NULL
analysis	NULL
using	NULL
primer	NULL
pair	NULL
P1	NULL
and	NULL
P5	NULL
,	NULL
perhaps	NULL
because	NULL
the	NULL
assay	NULL
was	NULL
not	NULL
sensitive	NULL
enough	NULL
to	NULL
detect	NULL
the	NULL
low	NULL
amounts	NULL
of	NULL
specific	NULL
NFATx3	NULL
mRNAs	NULL
.	NULL

These	NULL
results	NULL
indicated	NULL
that	NULL
NFATx1	NULL
,	NULL
NFATx2	NULL
,	NULL
and	NULL
NFATx3	NULL
mRNAs	NULL
were	NULL
expressed	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
and	NULL
that	NULL
NFATx1	NULL
appeared	NULL
to	NULL
be	NULL
the	NULL
predominant	NULL
species	NULL
.	NULL

We	NULL
further	NULL
investigated	NULL
the	NULL
relative	NULL
expression	NULL
of	NULL
NFAT	NULL
'	NULL
x	NULL
isoforms	NULL
in	NULL
thymus	NULL
,	NULL
skeletal	NULL
muscle	NULL
,	NULL
and	NULL
kidney	NULL
using	NULL
same	NULL
primers	NULL
(	NULL
P1	NULL
and	NULL
P5	NULL
)	NULL
as	NULL
those	NULL
used	NULL
for	NULL
RT-PCR	NULL
analysis	NULL
.	NULL

We	NULL
detected	NULL
the	NULL
same	NULL
two	NULL
amplification	NULL
products	NULL
as	NULL
in	NULL
the	NULL
Jurkat	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
,	NULL
lanes	NULL
6	NULL
,	NULL
9	NULL
,	NULL
and	NULL
12	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
thymus	NULL
and	NULL
kidney	NULL
exhibited	NULL
basically	NULL
the	NULL
NFATx1	NULL
mRNA	NULL
isoform	NULL
(	NULL
lower	NULL
band	NULL
,	NULL
lanes	NULL
6	NULL
and	NULL
12	NULL
)	NULL
,	NULL
while	NULL
skeletal	NULL
muscle	NULL
exhibited	NULL
primarily	NULL
the	NULL
NFATx2	NULL
mRNA	NULL
isoform	NULL
(	NULL
upper	NULL
band	NULL
,	NULL
lane	NULL
9	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicated	NULL
that	NULL
NFAT	NULL
x1	NULL
and	NULL
NFATx2	NULL
mRNA	NULL
isoforms	NULL
were	NULL
expressed	NULL
in	NULL
those	NULL
tissues	NULL
,	NULL
however	NULL
with	NULL
different	NULL
ratios	NULL
.	NULL

Again	NULL
,	NULL
we	NULL
did	NULL
not	NULL
detect	NULL
a	NULL
band	NULL
corresponding	NULL
to	NULL
NFAT	NULL
x3	NULL
in	NULL
these	NULL
tissues	NULL
by	NULL
this	NULL
analysis	NULL
.	NULL

Judging	NULL
from	NULL
these	NULL
results	NULL
,	NULL
although	NULL
we	NULL
did	NULL
detect	NULL
the	NULL
specific	NULL
NFATx3	NULL
mRNA	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lanes	NULL
6	NULL
,	NULL
7	NULL
,	NULL
and	NULL
9	NULL
)	NULL
,	NULL
the	NULL
amount	NULL
is	NULL
very	NULL
low	NULL
compared	NULL
with	NULL
those	NULL
of	NULL
NFATx1	NULL
and	NULL
NFATx2	NULL
mRNA	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
thymus	NULL
,	NULL
and	NULL
kidney	NULL
.	NULL

To	NULL
compare	NULL
the	NULL
relative	NULL
expression	NULL
levels	NULL
of	NULL
the	NULL
NFATx2	NULL
in	NULL
various	NULL
tissues	NULL
,	NULL
we	NULL
then	NULL
hybridized	NULL
a	NULL
human	NULL
multiple	NULL
tissue	NULL
blot	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
3460	NULL
with	NULL
an	NULL
NFATx2-specific	NULL
probe	NULL
consisting	NULL
of	NULL
the	NULL
insertion	NULL
sequence	NULL
of	NULL
NFATx2	NULL
cDNA	NULL
.	NULL

NFATx2	NULL
mRNA	NULL
,	NULL
which	NULL
had	NULL
the	NULL
same	NULL
apparent	NULL
size	NULL
(	NULL
7.0	NULL
kb	NULL
)	NULL
as	NULL
NFATx	NULL
mRNA	NULL
in	NULL
Figure	NULL
4A	NULL
,	NULL
was	NULL
detected	NULL
very	NULL
strongly	NULL
in	NULL
RNA	NULL
from	NULL
skeletal	NULL
muscle	NULL
and	NULL
weakly	NULL
in	NULL
RNA	NULL
from	NULL
testis	NULL
,	NULL
spleen	NULL
,	NULL
thymus	NULL
,	NULL
prostate	NULL
,	NULL
ovary	NULL
,	NULL
small	NULL
intestine	NULL
,	NULL
heart	NULL
,	NULL
placenta	NULL
,	NULL
and	NULL
pancreas	NULL
(	NULL
Fig	NULL
.	NULL

41D	NULL
)	NULL
.	NULL

We	NULL
did	NULL
not	NULL
detect	NULL
NFATx2	NULL
expression	NULL
in	NULL
kidney	NULL
.	NULL

We	NULL
also	NULL
hybridized	NULL
the	NULL
same	NULL
tissue	NULL
blot	NULL
with	NULL
an	NULL
NFATx3-	NULL
or	NULL
NFATx4-specific	NULL
probe	NULL
.	NULL

However	NULL
,	NULL
neither	NULL
NFATx3	NULL
nor	NULL
NFAT	NULL
x4	NULL
mRNA	NULL
was	NULL
detected	NULL
even	NULL
in	NULL
very	NULL
low	NULL
stringent	NULL
washing	NULL
conditions	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
the	NULL
NFAT	NULL
isoforms	NULL
with	NULL
altered	NULL
carboxyl	NULL
terminus	NULL
are	NULL
expressed	NULL
dif-ferentially	NULL
in	NULL
different	NULL
tissues	NULL
,	NULL
possibly	NULL
generated	NULL
by	NULL
tissue-specific	NULL
alternative	NULL
splicing	NULL
.	NULL

Transcriptional	NULL
activity	NULL
of	NULL
NFATx	NULL
isoforms	NULL
It	NULL
is	NULL
interesting	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
transcription	NULL
activity	NULL
of	NULL
the	NULL
NFAT	NULL
'	NULL
x	NULL
isoforms	NULL
is	NULL
modulated	NULL
by	NULL
alteration	NULL
of	NULL
last	NULL
amino	NULL
acid	NULL
residues	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
as	NULL
well	NULL
as	NULL
HEK	NULL
293	NULL
cells	NULL
,	NULL
since	NULL
all	NULL
three	NULL
isoforms	NULL
isolated	NULL
in	NULL
this	NULL
study	NULL
lack	NULL
the	NULL
transactivation	NULL
sequence	NULL
of	NULL
NFATx1	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
the	NULL
NFAT	NULL
'	NULL
x	NULL
isoforms	NULL
was	NULL
checked	NULL
by	NULL
the	NULL
transient	NULL
transfection	NULL
assay	NULL
described	NULL
above	NULL
.	NULL

The	NULL
transfected	NULL
Jurkat	NULL
cells	NULL
were	NULL
then	NULL
divided	NULL
into	NULL
three	NULL
sets	NULL
and	NULL
incubated	NULL
at	NULL
37°C	NULL
for	NULL
40	NULL
h.	NULL
The	NULL
cells	NULL
were	NULL
left	NULL
unstimulated	NULL
or	NULL
were	NULL
stimulated	NULL
either	NULL
with	NULL
PMA	NULL
or	NULL
with	NULL
a	NULL
combination	NULL
of	NULL
PMA	NULL
and	NULL
A23187	NULL
for	NULL
8	NULL
h	NULL
before	NULL
harvest	NULL
.	NULL

The	NULL
activity	NULL
attributed	NULL
to	NULL
endogenous	NULL
NFAT	NULL
was	NULL
detected	NULL
as	NULL
the	NULL
increase	NULL
in	NULL
luciferase	NULL
activity	NULL
upon	NULL
PMA/A23187	NULL
stimulation	NULL
of	NULL
cells	NULL
transfected	NULL
with	NULL
only	NULL
empty	NULL
vector	NULL
,	NULL
pME18S	NULL
(	NULL
Fig	NULL
.	NULL

54	NULL
)	NULL
.	NULL

Cotransfection	NULL
of	NULL
NFATx1	NULL
with	NULL
reporter	NULL
plasmid	NULL
caused	NULL
increase	NULL
in	NULL
NFAT-dependent	NULL
transactivation	NULL
by	NULL
eightfold	NULL
over	NULL
the	NULL
endogenous	NULL
NFAT	NULL
activity	NULL
.	NULL

Notably	NULL
,	NULL
transactivation	NULL
activity	NULL
mediated	NULL
by	NULL
NFATx2	NULL
,	NULL
NFATx3	NULL
,	NULL
or	NULL
NFATx4	NULL
was	NULL
markedly	NULL
lower	NULL
than	NULL
that	NULL
mediated	NULL
by	NULL
NFATx1	NULL
.	NULL

Stimulation	NULL
by	NULL
both	NULL
PMA	NULL
and	NULL
A23187	NULL
was	NULL
strictly	NULL
required	NULL
for	NULL
transactivation	NULL
in	NULL
all	NULL
cases	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
next	NULL
checked	NULL
the	NULL
function	NULL
of	NULL
NFAT	NULL
'	NULL
x	NULL
isoforms	NULL
by	NULL
transient	NULL
transfection	NULL
in	NULL
293	NULL
cells	NULL
,	NULL
since	NULL
fusion	NULL
between	NULL
the	NULL
15-amino	NULL
acid	NULL
transactivation	NULL
sequence	NULL
of	NULL
NFATx1	NULL
and	NULL
the	NULL
GAL4	NULL
DNA	NULL
binding	NULL
domain	NULL
was	NULL
capable	NULL
of	NULL
transactivating	NULL
reporters	NULL
driven	NULL
by	NULL
the	NULL
GALA	NULL
DNA	NULL
binding	NULL
site	NULL
in	NULL
this	NULL
cell	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
plasmid	NULL
of	NULL
each	NULL
NFATx	NULL
isoform	NULL
was	NULL
cotransfected	NULL
with	NULL
the	NULL
reporter	NULL
plasmid	NULL
NF-ATLuc	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
luciferase	NULL
gene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
seven	NULL
copies	NULL
of	NULL
the	NULL
murine	NULL
IL-2	NULL
distal	NULL
NFAT	NULL
site	NULL
.	NULL

The	NULL
plasmid	NULL
pBC12/RSV/SEAP	NULL
was	NULL
also	NULL
included	NULL
to	NULL
monitor	NULL
for	NULL
transfection	NULL
efficiency	NULL
.	NULL

Two	NULL
sets	NULL
of	NULL
transfection	NULL
were	NULL
performed	NULL
for	NULL
each	NULL
NFATx	NULL
isoform	NULL
and	NULL
were	NULL
incubated	NULL
at	NULL
37°C	NULL
for	NULL
40	NULL
h.	NULL
One	NULL
set	NULL
was	NULL
left	NULL
without	NULL
stimulation	NULL
,	NULL
while	NULL
the	NULL
other	NULL
set	NULL
was	NULL
stimulated	NULL
with	NULL
PMA	NULL
and	NULL
A23187	NULL
for	NULL
8	NULL
h.	NULL
Similar	NULL
to	NULL
results	NULL
with	NULL
Jurkat	NULL
cells	NULL
,	NULL
the	NULL
extract	NULL
from	NULL
cells	NULL
transfected	NULL
with	NULL
pME-NFATx1	NULL
showed	NULL
10	NULL
times	NULL
greater	NULL
activity	NULL
when	NULL
cells	NULL
were	NULL
stimulated	NULL
by	NULL
PMA/A23187	NULL
compared	NULL
with	NULL
mock	NULL
transfectant	NULL
(	NULL
pME18S	NULL
)	NULL
,	NULL
whereas	NULL
transfection	NULL
with	NULL
pME-NFATx2	NULL
,	NULL
pME-NFATx3	NULL
,	NULL
or	NULL
pME-NFATx4	NULL
gave	NULL
much	NULL
lower	NULL
activity	NULL
compared	NULL
with	NULL
NFATx1	NULL
cDNA	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

It	NULL
is	NULL
unlikely	NULL
that	NULL
lower	NULL
induction	NULL
of	NULL
luciferase	NULL
activity	NULL
by	NULL
transfection	NULL
of	NULL
the	NULL
NFATx	NULL
isoform	NULL
expression	NULL
plasmid	NULL
(	NULL
pME-NFATx2	NULL
,	NULL
-NFATx3	NULL
,	NULL
or	NULL
-NFATx4	NULL
)	NULL
is	NULL
due	NULL
to	NULL
a	NULL
failure	NULL
in	NULL
expression	NULL
,	NULL
because	NULL
comparable	NULL
NFAT	NULL
'	NULL
x	NULL
isoform	NULL
expression	NULL
was	NULL
confirmed	NULL
by	NULL
immunoblotting	NULL
using	NULL
an	NULL
antiserum	NULL
against	NULL
a	NULL
common	NULL
peptide	NULL
sequence	NULL
of	NULL
NFAT	NULL
isoforms	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
the	NULL
NFATx2-	NULL
,	NULL
NFATx3-	NULL
,	NULL
or	NULL
NFATx4-specific	NULL
sequence	NULL
affects	NULL
NFATx	NULL
DNA	NULL
binding	NULL
,	NULL
we	NULL
transfected	NULL
an	NULL
expression	NULL
plasmid	NULL
containing	NULL
the	NULL
full-length	NULL
cDNA	NULL
of	NULL
NFATx	NULL
isoforms	NULL
into	NULL
COS-7	NULL
cells	NULL
and	NULL
prepared	NULL
nuclear	NULL
and	NULL
cytosolic	NULL
extracts	NULL
from	NULL
the	NULL
transiently	NULL
transfected	NULL
cells	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
using	NULL
an	NULL
antiserum	NULL
against	NULL
the	NULL
peptide	NULL
in	NULL
the	NULL
amino	NULL
terminus	NULL
of	NULL
NFATx	NULL
TRANSACTIVATION	NULL
SEQUENCE	NULL
OF	NULL
NFATx1	NULL
pME18S	NULL
{	NULL
]	NULL
NFATx4	NULL
4	NULL
]	NULL
é	NULL
u	NULL
Z	NULL
ted	NULL
p	NULL
-	NULL
NFATx2	NULL
m	NULL
Unstimula	NULL
PMA/A23187	NULL
[	NULL
Z	NULL
]	NULL
Unstimulated	NULL
_	NULL
(	NULL
MW	NULL
)	NULL
PMwazsier	NULL
NUCLEAR	NULL
CtTOSfL	NULL
~-	NULL
;	NULL
&	NULL
&	NULL
P	NULL
&	NULL
C	NULL
«	NULL
&	NULL
&	NULL
&	NULL
g	NULL
“	NULL
?	NULL

``	NULL
&	NULL
&	NULL
II_	NULL
$	NULL
$	NULL
$	NULL
API	NULL
-+	NULL
-+	NULL
-	NULL
#	NULL
-	NULL
#	NULL
-+	NULL
“	NULL
4—NFAT	NULL
td	NULL
.	NULL

.	NULL

.+NFAT	NULL
UARUE	NULL
--	NULL
_	NULL
-	NULL
>	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9101112131415	NULL
FIGURE	NULL
5	NULL
.	NULL

Comparison	NULL
of	NULL
the	NULL
transactivation	NULL
potentials	NULL
of	NULL
NFAT	NULL
isoforms	NULL
in	NULL
Jurkat	NULL
cells	NULL
(	NULL
4	NULL
)	NULL
and	NULL
293	NULL
cells	NULL
(	NULL
B	NULL
)	NULL
.	NULL

A	NULL
,	NULL
Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
3	NULL
ug	NULL
of	NULL
the	NULL
reporter	NULL
plasmid	NULL
pNFAT72Luc	NULL
,	NULL
3	NULL
pug	NULL
of	NULL
the	NULL
internal	NULL
control	NULL
plasmid	NULL
pCMV/SEAP	NULL
,	NULL
and	NULL
6	NULL
ug	NULL
of	NULL
the	NULL
expression	NULL
plasmid	NULL
pME18S	NULL
,	NULL
pME-NFATx1	NULL
,	NULL
pME-NFATx2	NULL
,	NULL
pME-NFATx3	NULL
,	NULL
and	NULL
pME-NFATx4	NULL
.	NULL

B	NULL
,	NULL
293	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
1	NULL
pg	NULL
of	NULL
the	NULL
reporter	NULL
plasmid	NULL
NF-ATLuc	NULL
,	NULL
0.25	NULL
ug	NULL
of	NULL
the	NULL
internal	NULL
control	NULL
plasmid	NULL
pBC12/RSV/SEAP	NULL
,	NULL
and	NULL
2	NULL
ug	NULL
of	NULL
the	NULL
expression	NULL
plasmid	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
PMA	NULL
(	NULL
50	NULL
ng/m	NULL
!	NULL
)	NULL

and	NULL
calcium	NULL
ionophore	NULL
(	NULL
10	NULL
pg/ml	NULL
)	NULL
for	NULL
293	NULL
cells	NULL
and	NULL
with	NULL
PMA	NULL
only	NULL
or	NULL
PMA	NULL
and	NULL
calcium	NULL
ionophore	NULL
for	NULL
Jurkat	NULL
cells	NULL
for	NULL
8	NULL
h	NULL
before	NULL
harvesting	NULL
.	NULL

Luciferase	NULL
activity	NULL
was	NULL
assayed	NULL
as	NULL
described	NULL
in	NULL
Figure	NULL
1	NULL
.	NULL

The	NULL
data	NULL
are	NULL
averages	NULL
for	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

C	NULL
,	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
NFAT	NULL
'	NULL
x	NULL
isoforms	NULL
to	NULL
the	NULL
NFAT	NULL
binding	NULL
site	NULL
from	NULL
the	NULL
human	NULL
IL-2	NULL
promoter	NULL
.	NULL

EMSAs	NULL
were	NULL
conducted	NULL
with	NULL
nuclear	NULL
or	NULL
cytosolic	NULL
extracts	NULL
from	NULL
COS-7	NULL
cells	NULL
transfected	NULL
with	NULL
pME18S	NULL
(	NULL
Mock	NULL
)	NULL
,	NULL
pME-NFATx1	NULL
,	NULL
pME-NFATx2	NULL
,	NULL
pME-NFATx3	NULL
,	NULL
and	NULL
pME-NFATx4	NULL
.	NULL

The	NULL
presence	NULL
or	NULL
the	NULL
absence	NULL
of	NULL
AP-1	NULL
(	NULL
derived	NULL
from	NULL
Jurkat	NULL
cells	NULL
)	NULL
is	NULL
indicated	NULL
.	NULL

(	NULL
16	NULL
)	NULL
revealed	NULL
very	NULL
similar	NULL
levels	NULL
of	NULL
the	NULL
NFATx	NULL
isoform	NULL
proteins	NULL
in	NULL
extracts	NULL
of	NULL
the	NULL
transfected	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
also	NULL
transfected	NULL
the	NULL
empty	NULL
expression	NULL
vector	NULL
(	NULL
pME18S	NULL
)	NULL
as	NULL
a	NULL
mock	NULL
control	NULL
.	NULL

EMSAs	NULL
were	NULL
then	NULL
conducted	NULL
with	NULL
a	NULL
double-stranded	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
NFAT-binding	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
.	NULL

The	NULL
results	NULL
demonstrated	NULL
the	NULL
presence	NULL
of	NULL
DNA	NULL
binding	NULL
activities	NULL
in	NULL
extracts	NULL
from	NULL
cells	NULL
transfected	NULL
with	NULL
all	NULL
NFAT	NULL
'	NULL
x	NULL
isoforms	NULL
.	NULL

This	NULL
activity	NULL
was	NULL
absent	NULL
from	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
expression	NULL
vector	NULL
alone	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
In	NULL
agreement	NULL
with	NULL
previous	NULL
characterization	NULL
of	NULL
NFAT	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
,	NULL
exogenous	NULL
AP-1	NULL
polypeptides	NULL
were	NULL
needed	NULL
to	NULL
reconstitute	NULL
NFAT	NULL
binding	NULL
by	NULL
the	NULL
cytoplasmic	NULL
extract	NULL
from	NULL
NFAT-transfected	NULL
cells	NULL
.	NULL

Nuclear	NULL
extracts	NULL
,	NULL
on	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
did	NULL
not	NULL
require	NULL
exogenous	NULL
AP-1	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
.	NULL

These	NULL
results	NULL
collectively	NULL
indicate	NULL
that	NULL
no	NULL
difference	NULL
was	NULL
found	NULL
in	NULL
the	NULL
characteristics	NULL
of	NULL
DNA	NULL
binding	NULL
to	NULL
the	NULL
NFAT	NULL
site	NULL
among	NULL
NFATx	NULL
isoforms	NULL
and	NULL
further	NULL
support	NULL
the	NULL
idea	NULL
that	NULL
a	NULL
15-amino	NULL
acid	NULL
sequence	NULL
in	NULL
the	NULL
carboxyl	NULL
terminus	NULL
of	NULL
NFATx1	NULL
is	NULL
important	NULL
for	NULL
transactivation	NULL
activity	NULL
in	NULL
at	NULL
least	NULL
T	NULL
cells	NULL
(	NULL
Jurkat	NULL
)	NULL
and	NULL
kidney	NULL
cells	NULL
(	NULL
293	NULL
)	NULL
.	NULL

Discussion	NULL
We	NULL
showed	NULL
that	NULL
15-amino	NULL
acid	NULL
residues	NULL
in	NULL
the	NULL
carboxyl	NULL
terminus	NULL
of	NULL
NFATx1	NULL
(	NULL
DITLDDVNEIIGRDM	NULL
)	NULL
were	NULL
essential	NULL
for	NULL
supporting	NULL
the	NULL
transactivation	NULL
function	NULL
of	NULL
NFATx1	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
and	NULL
confirmed	NULL
that	NULL
these	NULL
amino	NULL
acids	NULL
comprise	NULL
a	NULL
transcriptional	NULL
activation	NULL
sequence	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
amino	NULL
acid	NULL
substitution	NULL
proves	NULL
that	NULL
this	NULL
sequence	NULL
constitutes	NULL
a	NULL
motif	NULL
required	NULL
for	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
activation	NULL
mediated	NULL
by	NULL
this	NULL
15-amino	NULL
acid	NULL
sequence	NULL
is	NULL
lost	NULL
when	NULL
its	NULL
hydrophobic	NULL
residues	NULL
(	NULL
leucine	NULL
,	NULL
valine	NULL
,	NULL
and	NULL
isoleucine	NULL
)	NULL
are	NULL
nonconservatively	NULL
replaced	NULL
by	NULL
alanine	NULL
.	NULL

Consistently	NULL
,	NULL
those	NULL
hydrophobic	NULL
residues	NULL
are	NULL
perfectly	NULL
conserved	NULL
among	NULL
NFAT	NULL
family	NULL
proteins	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

The	NULL
mechanism	NULL
of	NULL
the	NULL
transactivation	NULL
remains	NULL
unknown	NULL
,	NULL
but	NULL
this	NULL
15-amino	NULL
acid	NULL
transactivation	NULL
sequence	NULL
increases	NULL
the	NULL
transactivation	NULL
function	NULL
of	NULL
NFATx1	NULL
by	NULL
enhancing	NULL
its	NULL
ability	NULL
to	NULL
interact	NULL
with	NULL
coactivator	NULL
or	NULL
other	NULL
components	NULL
of	NULL
the	NULL
general	NULL
transcription	NULL
apparatus	NULL
,	NULL
and	NULL
alanine	NULL
substitution	NULL
of	NULL
this	NULL
sequence	NULL
may	NULL
cause	NULL
disruption	NULL
of	NULL
this	NULL
interaction	NULL
.	NULL

The	NULL
transcription-activating	NULL
domains	NULL
of	NULL
other	NULL
transcription	NULL
factors	NULL
have	NULL
often	NULL
been	NULL
classified	NULL
according	NULL
to	NULL
the	NULL
predominant	NULL
amino	NULL
acids	NULL
contained	NULL
therein	NULL
.	NULL

For	NULL
example	NULL
,	NULL
acidic	NULL
domain	NULL
,	NULL
glutamine-rich	NULL
,	NULL
and	NULL
proline-rich	NULL
(	NULL
26	NULL
)	NULL
as	NULL
well	NULL
as	NULL
glycine-rich	NULL
(	NULL
27	NULL
)	NULL
or	NULL
isoleucine-rich	NULL
(	NULL
28	NULL
)	NULL
activating	NULL
segments	NULL
have	NULL
been	NULL
identi-fied	NULL
.	NULL

Notably	NULL
,	NULL
the	NULL
15-amino	NULL
acid	NULL
transactivation	NULL
sequence	NULL
in	NULL
NFATx1	NULL
does	NULL
not	NULL
contain	NULL
typical	NULL
amino	NULL
acid	NULL
residues	NULL
for	NULL
transactivation	NULL
domains	NULL
,	NULL
except	NULL
for	NULL
the	NULL
five	NULL
acidic	NULL
amino	NULL
acids	NULL
(	NULL
glu-tamic	NULL
and	NULL
aspartic	NULL
)	NULL
.	NULL

Although	NULL
some	NULL
transcription-activating	NULL
domains	NULL
can	NULL
be	NULL
induced	NULL
to	NULL
fold	NULL
into	NULL
a-helixes	NULL
(	NULL
26	NULL
)	NULL
,	NULL
it	NULL
appears	NULL
the	NULL
transactivation	NULL
sequence	NULL
in	NULL
NFATx1	NULL
does	NULL
not	NULL
allow	NULL
a	NULL
helix/coil	NULL
structure	NULL
as	NULL
predicted	NULL
by	NULL
the	NULL
algorithm	NULL
AGADIR	NULL
(	NULL
29	NULL
)	NULL
.	NULL

We	NULL
also	NULL
have	NULL
isolated	NULL
the	NULL
cDNAs	NULL
encoding	NULL
three	NULL
isoforms	NULL
of	NULL
NFATx	NULL
that	NULL
have	NULL
different	NULL
carboxyl-terminal	NULL
ends	NULL
in	NULL
this	NULL
study	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

As	NULL
a	NULL
result	NULL
,	NULL
the	NULL
transactivation	NULL
sequence	NULL
of	NULL
NFATx1	NULL
is	NULL
replaced	NULL
for	NULL
these	NULL
isoforms	NULL
.	NULL

Consistently	NULL
,	NULL
transactivation	NULL
activity	NULL
mediated	NULL
by	NULL
NFATx	NULL
isoforms	NULL
NFATx2	NULL
,	NULL
NFATx3	NULL
,	NULL
and	NULL
NFATx4	NULL
was	NULL
lower	NULL
than	NULL
that	NULL
for	NULL
NFATx1	NULL
in	NULL
Jurkat	NULL
as	NULL
well	NULL
as	NULL
293	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

We	NULL
also	NULL
showed	NULL
that	NULL
the	NULL
different	NULL
carboxyl-terminal	NULL
ends	NULL
did	NULL
not	NULL
affect	NULL
DNA	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
the	NULL
NFATx	NULL
isoforms	NULL
were	NULL
shown	NULL
to	NULL
have	NULL
relatively	NULL
similar	NULL
binding	NULL
affinities	NULL
to	NULL
the	NULL
NFAT	NULL
site	NULL
using	NULL
a	NULL
competition	NULL
experiment	NULL
with	NULL
increasing	NULL
amounts	NULL
of	NULL
unlabeled	NULL
probe	NULL
in	NULL
the	NULL
EMSA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
data	NULL
indicated	NULL
the	NULL
importance	NULL
of	NULL
the	NULL
transactivation	NULL
sequence	NULL
of	NULL
NFATx1	NULL
in	NULL
Jurkat	NULL
and	NULL
293	NULL
cells	NULL
and	NULL
also	NULL
suggested	NULL
that	NULL
NFAT	NULL
'	NULL
x	NULL
has	NULL
a	NULL
transactivation	NULL
sequence	NULL
as	NULL
a	NULL
module	NULL
,	NULL
and	NULL
this	NULL
sequence	NULL
is	NULL
replaced	NULL
by	NULL
a	NULL
different	NULL
sequence	NULL
for	NULL
a	NULL
different	NULL
isoform	NULL
.	NULL

It	NULL
is	NULL
known	NULL
that	NULL
truncation	NULL
of	NULL
the	NULL
activation	NULL
domain	NULL
of	NULL
several	NULL
transcription	NULL
factors	NULL
,	NULL
such	NULL
as	NULL
STAT	NULL
,	NULL
retinoic	NULL
acid	NULL
receptor	NULL
,	NULL
and	NULL
hepatocyte	NULL
nuclear	NULL
factor	NULL
,	NULL
turn	NULL
them	NULL
into	NULL
dominant	NULL
negative	NULL
re-pressors	NULL
of	NULL
the	NULL
normal	NULL
forms	NULL
(	NULL
30-32	NULL
)	NULL
.	NULL

However	NULL
,	NULL
a	NULL
carboxyl-terminal	NULL
deletion	NULL
mutant	NULL
of	NULL
NFATx1	NULL
(	NULL
NFATx1AC	NULL
)	NULL
and	NULL
newly	NULL
isolated	NULL
NFATx	NULL
isoforms	NULL
(	NULL
NFATx2	NULL
,	NULL
NFATx3	NULL
,	NULL
and	NULL
NFATx4	NULL
)	NULL
that	NULL
showed	NULL
lower	NULL
transactivation	NULL
activity	NULL
than	NULL
that	NULL
of	NULL
NFATx1	NULL
(	NULL
Figs	NULL
.	NULL

3461	NULL
Table	NULL
1	NULL
.	NULL

-	NULL
Human	NULL
and	NULL
murine	NULL
isoforms	NULL
of	NULL
NFAT	NULL
family	NULL
members	NULL
``	NULL
Human	NULL
Isoforms	NULL
Ref	NULL
.	NULL

_	NULL
Murine	NULL
Isoforms	NULL
-	NULL
Ref	NULL
.	NULL

NFATx	NULL
NFATx1	NULL
10	NULL
,	NULL
*	NULL
mNFATx1	NULL
33	NULL
(	NULL
NFAT4	NULL
)	NULL
-	NULL
NFATx2	NULL
*	NULL
mNFATx2	NULL
33	NULL
(	NULL
NFATc3	NULL
)	NULL
NFATx3	NULL
*	NULL
NFATx4	NULL
*	NULL
NFAT4a	NULL
9	NULL
NFATA4b	NULL
9	NULL
NFAT4c	NULL
(	NULL
NFATx2	NULL
)	NULL
-	NULL
9	NULL
,	NULL
*	NULL
NFATc3	NULL
13	NULL
NFATI	NULL
NFATIA	NULL
35	NULL
(	NULL
NFATp	NULL
)	NULL
-	NULL
NFATIB	NULL
35	NULL
NFATIB	NULL
35	NULL
(	NULL
NFATe2	NULL
)	NULL
NFATIC	NULL
35	NULL
NFATIC	NULL
35	NULL
NFATc	NULL
(	NULL
NFAT2	NULL
)	NULL
NFATc	NULL
(	NULL
NFATc.a	NULL
)	NULL
12,36	NULL
_	NULL
mNFATc	NULL
43	NULL
(	NULL
NFATcel	NULL
)	NULL
NFATc.B	NULL
36	NULL
NFAT3	NULL
NFAT3	NULL
9	NULL
``	NULL
Previous	NULL
studies	NULL
are	NULL
referenced	NULL
,	NULL
and	NULL
asterisks	NULL
indicate	NULL
this	NULL
study	NULL
.	NULL

1B	NULL
,	NULL
5A	NULL
,	NULL
and	NULL
5B	NULL
)	NULL
did	NULL
not	NULL
affect	NULL
NFAT	NULL
transactivation	NULL
as	NULL
measured	NULL
in	NULL
a	NULL
cotransfection	NULL
assay	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Independently	NULL
,	NULL
Hoey	NULL
et	NULL
al	NULL
.	NULL

previously	NULL
reported	NULL
the	NULL
sequences	NULL
of	NULL
three	NULL
isoforms	NULL
of	NULL
NFATx/NFAT4	NULL
,	NULL
designated	NULL
NFAT4a	NULL
,	NULL
NFAT4b	NULL
,	NULL
and	NULL
NFAT4c	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Sequence	NULL
comparison	NULL
between	NULL
isoforms	NULL
of	NULL
NFAT4	NULL
and	NULL
NFATx	NULL
showed	NULL
that	NULL
NFATx2	NULL
,	NULL
which	NULL
we	NULL
isolated	NULL
in	NULL
this	NULL
study	NULL
,	NULL
was	NULL
identical	NULL
with	NULL
NFAT4c	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
NFATx/	NULL
NFAT4	NULL
has	NULL
at	NULL
least	NULL
six	NULL
isoforms	NULL
,	NULL
named	NULL
NFATx1	NULL
,	NULL
NFATx2	NULL
(	NULL
NFATA4c	NULL
)	NULL
,	NULL
NFATx3	NULL
,	NULL
NFATx4	NULL
,	NULL
NFAT4a	NULL
,	NULL
and	NULL
NFAT4b	NULL
.	NULL

Unlike	NULL
NFATx	NULL
isoforms	NULL
,	NULL
the	NULL
divergence	NULL
of	NULL
the	NULL
sequences	NULL
of	NULL
NFAT4a	NULL
and	NULL
NFAT	NULL
4b	NULL
isoforms	NULL
begins	NULL
just	NULL
downstream	NULL
of	NULL
the	NULL
Rel	NULL
similarity	NULL
region	NULL
,	NULL
where	NULL
the	NULL
carboxyl-terminal	NULL
regions	NULL
are	NULL
much	NULL
shorter	NULL
(	NULL
9	NULL
and	NULL
40	NULL
amino	NULL
acid	NULL
residues	NULL
for	NULL
Figure	NULL
4	NULL
,	NULL
A	NULL
and	NULL
B	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
we	NULL
also	NULL
cloned	NULL
mouse	NULL
counterparts	NULL
of	NULL
NFATx1	NULL
and	NULL
NFATx2	NULL
,	NULL
designated	NULL
mNFATx1	NULL
and	NULL
mNFATx2	NULL
,	NULL
from	NULL
a	NULL
murine	NULL
EL-4	NULL
cDNA	NULL
library	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
a	NULL
truncated	NULL
version	NULL
of	NULL
the	NULL
mouse	NULL
counterpart	NULL
of	NULL
human	NULL
NFATx1	NULL
,	NULL
designated	NULL
NFATc3	NULL
,	NULL
was	NULL
also	NULL
isolated	NULL
from	NULL
a	NULL
cDNA	NULL
library	NULL
derived	NULL
from	NULL
the	NULL
thymus	NULL
of	NULL
a	NULL
TCR	NULL
transgenic	NULL
mouse	NULL
by	NULL
Ho	NULL
et	NULL
al	NULL
.	NULL

(	NULL
13	NULL
)	NULL
.	NULL

The	NULL
existence	NULL
of	NULL
isoforms	NULL
has	NULL
been	NULL
reported	NULL
for	NULL
NFATI	NULL
(	NULL
NE	NULL
ATp	NULL
)	NULL
.	NULL

Three	NULL
isoforms	NULL
of	NULL
NFATI	NULL
(	NULL
NFATp	NULL
)	NULL
(	NULL
NFAT1-A	NULL
,	NULL
NFAT1-B	NULL
,	NULL
and	NULL
NFAT1-C	NULL
)	NULL
were	NULL
isolated	NULL
from	NULL
a	NULL
Jurkat	NULL
cDNA	NULL
library	NULL
(	NULL
34	NULL
,	NULL
35	NULL
)	NULL
.	NULL

As	NULL
with	NULL
NFATx	NULL
isoforms	NULL
,	NULL
the	NULL
very	NULL
ends	NULL
of	NULL
the	NULL
carboxyl-terminal	NULL
region	NULL
of	NULL
NFATI	NULL
(	NULL
NFATp	NULL
)	NULL
isoforms	NULL
are	NULL
replaced	NULL
by	NULL
unrelated	NULL
amino	NULL
acid	NULL
residues	NULL
.	NULL

Similarly	NULL
,	NULL
an	NULL
NFATe	NULL
isoform	NULL
with	NULL
a	NULL
distinctive	NULL
sequence	NULL
of	NULL
the	NULL
carboxyl-terminal	NULL
region	NULL
,	NULL
designated	NULL
NFATc.B	NULL
,	NULL
was	NULL
recently	NULL
reported	NULL
(	NULL
36	NULL
)	NULL
.	NULL

It	NULL
appears	NULL
,	NULL
then	NULL
,	NULL
that	NULL
the	NULL
existence	NULL
of	NULL
multiple	NULL
isoforms	NULL
is	NULL
a	NULL
characteristic	NULL
of	NULL
NFAT	NULL
proteins	NULL
(	NULL
Table	NULL
D	NULL
)	NULL
.	NULL

We	NULL
previously	NULL
reported	NULL
Northern	NULL
blot	NULL
analysis	NULL
data	NULL
showing	NULL
that	NULL
NFATx	NULL
was	NULL
expressed	NULL
predominantly	NULL
in	NULL
thymus	NULL
and	NULL
at	NULL
lower	NULL
levels	NULL
in	NULL
peripheral	NULL
blood	NULL
leukocytes	NULL
.	NULL

In	NULL
that	NULL
analysis	NULL
,	NULL
we	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
Bgill	NULL
cDNA	NULL
fragment	NULL
(	NULL
positions	NULL
2698-3235	NULL
)	NULL
that	NULL
contained	NULL
a	NULL
common	NULL
sequence	NULL
of	NULL
all	NULL
NFAT	NULL
isoforms	NULL
and	NULL
an	NULL
NFATx1-spe-cific	NULL
sequence	NULL
(	NULL
10	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
we	NULL
used	NULL
a	NULL
different	NULL
cDNA	NULL
probe	NULL
(	NULL
positions	NULL
1156-2614	NULL
)	NULL
whose	NULL
sequence	NULL
was	NULL
common	NULL
in	NULL
all	NULL
four	NULL
NFATx	NULL
isoforms	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
.	NULL

Using	NULL
this	NULL
probe	NULL
,	NULL
we	NULL
detected	NULL
significant	NULL
NFATx	NULL
expression	NULL
in	NULL
various	NULL
tissues	NULL
,	NULL
such	NULL
as	NULL
testis	NULL
,	NULL
ovary	NULL
,	NULL
skeletal	NULL
muscle	NULL
,	NULL
and	NULL
kidney	NULL
as	NULL
well	NULL
as	NULL
in	NULL
thymus	NULL
and	NULL
leukocytes	NULL
.	NULL

These	NULL
observations	NULL
prompted	NULL
us	NULL
to	NULL
examine	NULL
the	NULL
possibility	NULL
of	NULL
differential	NULL
expression	NULL
of	NULL
the	NULL
NFATx	NULL
mRNA	NULL
isoforms	NULL
.	NULL

Interestingly	NULL
,	NULL
RT-PCR	NULL
and	NULL
Northern	NULL
blot	NULL
analyses	NULL
with	NULL
probes	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
3462	NULL
TRANSACTIVATION	NULL
SEQUENCE	NULL
OF	NULL
NFATx1	NULL
NFATxi	NULL
M	NULL
[	NULL
]	NULL
FIGURE	NULL
6	NULL
.	NULL

Comparison	NULL
of	NULL
amino	NULL
acid	NULL
sequences	NULL
in	NULL
the	NULL
carboxyl-terminal	NULL
end	NULL
of	NULL
NFATx1	NULL
,	NULL
NFATI-C	NULL
,	NULL
and	NULL
NFAT3	NULL
.	NULL

Asterisks	NULL
denote	NULL
sequence	NULL
identity	NULL
,	NULL
and	NULL
dots	NULL
denote	NULL
sequence	NULL
similarity	NULL
with	NULL
NFATx1	NULL
.	NULL

The	NULL
transactivation	NULL
sequence	NULL
of	NULL
NFATx1	NULL
and	NULL
corresponding	NULL
residues	NULL
in	NULL
NFATI-C	NULL
and	NULL
NFAT3	NULL
are	NULL
boxed	NULL
.	NULL

Joints	NULL
for	NULL
NFATx	NULL
isoforms	NULL
and	NULL
NFATI	NULL
(	NULL
NFATp	NULL
)	NULL
isoforms	NULL
are	NULL
indicated	NULL
by	NULL
the	NULL
black	NULL
bar	NULL
.	NULL

*e	NULL
[	NULL
n+l	NULL
ok	NULL
NFAT1-C	NULL
886	NULL
EVLPAGVTIKQEQNLDOTYLD	NULL
NFAT3	NULL
specific	NULL
for	NULL
either	NULL
NFATx1	NULL
or	NULL
NFATx2	NULL
showed	NULL
a	NULL
significant	NULL
difference	NULL
in	NULL
the	NULL
ratio	NULL
of	NULL
the	NULL
two	NULL
NFAT	NULL
'	NULL
x	NULL
mRNA	NULL
isoforms	NULL
in	NULL
different	NULL
tissues	NULL
.	NULL

Although	NULL
our	NULL
RT-PCR	NULL
analysis	NULL
showed	NULL
the	NULL
existence	NULL
of	NULL
NFATx3	NULL
and	NULL
NFATx4	NULL
mRNA	NULL
species	NULL
in	NULL
several	NULL
tissues	NULL
with	NULL
distinct	NULL
expression	NULL
patterns	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
,	NULL
we	NULL
could	NULL
not	NULL
detect	NULL
those	NULL
mRNA	NULL
species	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
using	NULL
multiple	NULL
tissue	NULL
blot	NULL
,	NULL
suggesting	NULL
that	NULL
NFATx3	NULL
and	NULL
NFATx4	NULL
isoforms	NULL
are	NULL
relatively	NULL
minor	NULL
species	NULL
compared	NULL
with	NULL
NFATx1	NULL
and	NULL
NFATx2	NULL
isoforms	NULL
in	NULL
those	NULL
tissues	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
NFATx1	NULL
and	NULL
NFATx2	NULL
are	NULL
major	NULL
mRNA	NULL
species	NULL
,	NULL
at	NULL
least	NULL
in	NULL
thymus	NULL
,	NULL
leukocytes	NULL
,	NULL
and	NULL
skeletal	NULL
muscle	NULL
tissues	NULL
.	NULL

The	NULL
thymus	NULL
and	NULL
leukocytes	NULL
expressed	NULL
primarily	NULL
NFATx1	NULL
mRNA	NULL
,	NULL
while	NULL
skeletal	NULL
muscle	NULL
expressed	NULL
predominantly	NULL
NFATx2	NULL
mRNA	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
C	NULL
and	NULL
D	NULL
)	NULL
.	NULL

Accordingly	NULL
,	NULL
the	NULL
cDNA	NULL
of	NULL
NFAT4c	NULL
,	NULL
which	NULL
is	NULL
identical	NULL
with	NULL
that	NULL
of	NULL
NFATx2	NULL
,	NULL
was	NULL
cloned	NULL
from	NULL
a	NULL
skeletal	NULL
muscle	NULL
tissue	NULL
cDNA	NULL
library	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Although	NULL
our	NULL
RT-PCR	NULL
analysis	NULL
showed	NULL
that	NULL
NFATx1	NULL
mRNA	NULL
was	NULL
present	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
,	NULL
lane	NULL
12	NULL
)	NULL
,	NULL
it	NULL
is	NULL
notable	NULL
that	NULL
the	NULL
Bg/lI	NULL
cDNA	NULL
fragment	NULL
from	NULL
NFATx1	NULL
did	NULL
not	NULL
strongly	NULL
hybridize	NULL
with	NULL
mRNA	NULL
from	NULL
kidney	NULL
.	NULL

It	NULL
is	NULL
thus	NULL
possible	NULL
that	NULL
another	NULL
NFAT	NULL
'	NULL
x	NULL
isoform	NULL
is	NULL
expressed	NULL
in	NULL
kidney	NULL
.	NULL

Since	NULL
the	NULL
tissues	NULL
in	NULL
which	NULL
we	NULL
detected	NULL
expression	NULL
of	NULL
NFATx	NULL
mRNA	NULL
isoforms	NULL
,	NULL
such	NULL
as	NULL
thymus	NULL
,	NULL
skeletal	NULL
muscle	NULL
,	NULL
and	NULL
kidney	NULL
,	NULL
consist	NULL
of	NULL
various	NULL
types	NULL
of	NULL
cells	NULL
,	NULL
it	NULL
is	NULL
important	NULL
to	NULL
identify	NULL
what	NULL
types	NULL
of	NULL
cells	NULL
in	NULL
tissues	NULL
express	NULL
those	NULL
isoforms	NULL
to	NULL
investigate	NULL
their	NULL
function	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
can	NULL
not	NULL
completely	NULL
rule	NULL
out	NULL
the	NULL
possibilities	NULL
that	NULL
expression	NULL
of	NULL
NFAT	NULL
genes	NULL
are	NULL
under	NULL
translational	NULL
control	NULL
and	NULL
that	NULL
NFAT	NULL
proteins	NULL
are	NULL
not	NULL
necessarily	NULL
found	NULL
in	NULL
all	NULL
tissues	NULL
in	NULL
which	NULL
the	NULL
genes	NULL
are	NULL
transcribed	NULL
.	NULL

The	NULL
use	NULL
of	NULL
isoform-specific	NULL
Abs	NULL
should	NULL
help	NULL
us	NULL
resolve	NULL
these	NULL
issues	NULL
.	NULL

The	NULL
role	NULL
of	NULL
NFAT	NULL
proteins	NULL
in	NULL
skeletal	NULL
muscle	NULL
and	NULL
kidney	NULL
tissues	NULL
is	NULL
unknown	NULL
.	NULL

One	NULL
potential	NULL
target	NULL
for	NULL
NFAT	NULL
proteins	NULL
in	NULL
these	NULL
tissues	NULL
could	NULL
be	NULL
the	NULL
IL-15	NULL
gene	NULL
,	NULL
whose	NULL
mRNA	NULL
expression	NULL
was	NULL
observed	NULL
outside	NULL
the	NULL
lymphoid	NULL
system	NULL
;	NULL
in	NULL
particular	NULL
,	NULL
skeletal	NULL
muscle	NULL
,	NULL
kidney	NULL
,	NULL
placenta	NULL
,	NULL
and	NULL
lung	NULL
expressed	NULL
IL-15	NULL
mRNA	NULL
strongly	NULL
,	NULL
whereas	NULL
lymphoid	NULL
organs	NULL
,	NULL
such	NULL
as	NULL
spleen	NULL
and	NULL
thymus	NULL
,	NULL
expressed	NULL
lesser	NULL
quantities	NULL
of	NULL
the	NULL
transcript	NULL
(	NULL
37	NULL
,	NULL
38	NULL
)	NULL
.	NULL

Alternatively	NULL
,	NULL
it	NULL
is	NULL
also	NULL
possible	NULL
that	NULL
target	NULL
genes	NULL
of	NULL
NFAT	NULL
proteins	NULL
are	NULL
other	NULL
than	NULL
cytokine	NULL
genes	NULL
.	NULL

Interestingly	NULL
,	NULL
recent	NULL
gene	NULL
targeting	NULL
and	NULL
a	NULL
transgene	NULL
approach	NULL
suggest	NULL
that	NULL
NFAT	NULL
family	NULL
proteins	NULL
have	NULL
unique	NULL
target	NULL
genes	NULL
other	NULL
than	NULL
cytokine	NULL
genes	NULL
in	NULL
heart	NULL
(	NULL
39-41	NULL
)	NULL
.	NULL

No	NULL
obvious	NULL
abnormality	NULL
was	NULL
reported	NULL
in	NULL
the	NULL
skeletal	NULL
muscle	NULL
and	NULL
kidney	NULL
of	NULL
mice	NULL
deficient	NULL
in	NULL
NFAT1	NULL
(	NULL
NFATp	NULL
)	NULL
or	NULL
NFATc	NULL
protein	NULL
(	NULL
39	NULL
,	NULL
40	NULL
,	NULL
42	NULL
)	NULL
.	NULL

The	NULL
development	NULL
of	NULL
mice	NULL
deficient	NULL
in	NULL
other	NULL
NFAT	NULL
proteins	NULL
(	NULL
NFATx	NULL
and	NULL
NFAT3	NULL
)	NULL
will	NULL
help	NULL
us	NULL
understand	NULL
the	NULL
roles	NULL
of	NULL
the	NULL
NFAT	NULL
family	NULL
proteins	NULL
in	NULL
these	NULL
tissues	NULL
.	NULL

Significantly	NULL
,	NULL
the	NULL
transactivation	NULL
sequence	NULL
of	NULL
NFATx1	NULL
that	NULL
we	NULL
identified	NULL
in	NULL
this	NULL
study	NULL
was	NULL
also	NULL
found	NULL
in	NULL
NFAT1-C	NULL
,	NULL
one	NULL
of	NULL
the	NULL
NFATI	NULL
(	NULL
NFATp	NULL
)	NULL
isoforms	NULL
,	NULL
and	NULL
in	NULL
NFAT3	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
a	NULL
Leka	NULL
u	NULL
EIIRKEFSGPPARNQT	NULL
NFATx1	NULL
1014	NULL
PEPEDREPNFATIGLQDITLDszEIIGRDMSQISVSQGAGVSRQAPLPSPESLDLGRSDGL	NULL
[	NULL
x	NULL
+	NULL
e	NULL
»	NULL
mele	NULL
cie	NULL
kee	NULL
de	NULL
eee	NULL
``	NULL
Bek	NULL
.e	NULL
.+	NULL
*	NULL
859	NULL
SRGCYSSGFRDSVPIQEITLEEVSEIIGRDLECFPAPPGEEPPA	NULL
GALA	NULL
DNA	NULL
binding	NULL
domain	NULL
fused	NULL
to	NULL
the	NULL
very	NULL
end	NULL
of	NULL
carboxyl-terminal	NULL
region	NULL
of	NULL
NFAT1-C	NULL
or	NULL
NFAT3	NULL
,	NULL
which	NULL
contains	NULL
a	NULL
sequence	NULL
corresponding	NULL
with	NULL
the	NULL
NFATx1	NULL
transactivation	NULL
sequence	NULL
also	NULL
showed	NULL
transactivation	NULL
potential	NULL
(	NULL
R.	NULL
Imamura	NULL
,	NULL
E.	NULL
S.	NULL
Masuda	NULL
,	NULL
and	NULL
N.	NULL
Arai	NULL
,	NULL
unpublished	NULL
observation	NULL
)	NULL
.	NULL

Consistently	NULL
,	NULL
Luo	NULL
et	NULL
al	NULL
.	NULL

showed	NULL
that	NULL
NFAT1-C	NULL
was	NULL
the	NULL
most	NULL
potent	NULL
transcriptional	NULL
activa-tor	NULL
among	NULL
NFATI	NULL
(	NULL
NFATp	NULL
)	NULL
(	NULL
35	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
they	NULL
showed	NULL
that	NULL
a	NULL
GALA	NULL
DNA	NULL
binding	NULL
domain	NULL
fused	NULL
to	NULL
the	NULL
carboxyl-terminal	NULL
domain	NULL
of	NULL
NFAT1-C	NULL
contained	NULL
intrinsic	NULL
transactivation	NULL
potential	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
we	NULL
identified	NULL
a	NULL
novel	NULL
category	NULL
of	NULL
transactivation	NULL
sequence	NULL
in	NULL
the	NULL
carboxyl-terminal	NULL
region	NULL
of	NULL
NFATx1	NULL
,	NULL
a	NULL
major	NULL
transactivation	NULL
domain	NULL
of	NULL
NFATx	NULL
,	NULL
carrying	NULL
a	NULL
15-amino	NULL
acid	NULL
sequence	NULL
that	NULL
gives	NULL
potent	NULL
transactivation	NULL
function	NULL
.	NULL

We	NULL
also	NULL
isolated	NULL
novel	NULL
mRNA	NULL
isoforms	NULL
of	NULL
human	NULL
NFAT	NULL
'	NULL
x	NULL
(	NULL
NFATx2	NULL
,	NULL
-x3	NULL
,	NULL
and	NULL
-x4	NULL
)	NULL
that	NULL
show	NULL
distinct	NULL
tissue	NULL
distribution	NULL
patterns	NULL
;	NULL
ie	NULL
.	NULL

,	NULL
expression	NULL
of	NULL
NFATx	NULL
1	NULL
is	NULL
preferentially	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
that	NULL
of	NULL
NFATx2	NULL
is	NULL
high	NULL
in	NULL
skeletal	NULL
muscle	NULL
tissue	NULL
.	NULL

Among	NULL
these	NULL
isoforms	NULL
,	NULL
only	NULL
NFATx1	NULL
,	NULL
which	NULL
carries	NULL
the	NULL
complete	NULL
15-amino	NULL
acid	NULL
transactivation	NULL
sequence	NULL
,	NULL
shows	NULL
higher	NULL
transactivation	NULL
activity	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
sequence	NULL
seems	NULL
to	NULL
be	NULL
conserved	NULL
in	NULL
other	NULL
NFAT	NULL
family	NULL
members	NULL
and	NULL
may	NULL
explain	NULL
the	NULL
tissue-specific	NULL
transactivation	NULL
function	NULL
of	NULL
NFAT	NULL
family	NULL
proteins	NULL
.	NULL

Thus	NULL
,	NULL
this	NULL
observation	NULL
may	NULL
be	NULL
useful	NULL
for	NULL
developing	NULL
reagents	NULL
that	NULL
block	NULL
NFAT	NULL
activity	NULL
in	NULL
specific	NULL
tissues	NULL
.	NULL

Acknowledgments	NULL
We	NULL
are	NULL
grateful	NULL
to	NULL
Lisako	NULL
Tsuruta	NULL
for	NULL
providing	NULL
plasmids	NULL
NF-ATLuc	NULL
and	NULL
pNFAT72Luc	NULL
,	NULL
to	NULL
Shaida	NULL
Behnam	NULL
for	NULL
technical	NULL
assistance	NULL
,	NULL
and	NULL
to	NULL
Debra	NULL
Ligget	NULL
for	NULL
oligonucleotide	NULL
synthesis	NULL
.	NULL

We	NULL
thank	NULL
Drs	NULL
.	NULL

Joseph	NULL
Bolen	NULL
,	NULL
Timothy	NULL
Hoey	NULL
,	NULL
J.	NULL
Fernando	NULL
Bazan	NULL
,	NULL
and	NULL
Jie	NULL
Liu	NULL
for	NULL
helpful	NULL
discussions	NULL
,	NULL
and	NULL
Dr.	NULL
Dovie	NULL
Wylie	NULL
for	NULL
reading	NULL
the	NULL
manuscript	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Shaw	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
P.	NULL
J.	NULL
Utz	NULL
,	NULL
D.	NULL
B.	NULL
Durand	NULL
,	NULL
J.	NULL
J.	NULL
Toole	NULL
,	NULL
E.	NULL
A.	NULL
Emmel	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1988	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
putative	NULL
regulator	NULL
of	NULL
early	NULL
T	NULL
cell	NULL
activation	NULL
genes	NULL
.	NULL

Science	NULL
241:202	NULL
.	NULL

2	NULL
.	NULL

Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
and	NULL
N.	NULL
A.	NULL
Clipstone	NULL
.	NULL

1994	NULL
.	NULL

Signal	NULL
transmission	NULL
between	NULL
the	NULL
plasma	NULL
membrane	NULL
and	NULL
nucleus	NULL
of	NULL
T	NULL
lymphocytes	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

63:1045	NULL
.	NULL

3	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
C.	NULL
Loh	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1995	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

7:333	NULL
.	NULL

4	NULL
.	NULL

Hodge	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
A.	NULL
M.	NULL
Ranger	NULL
,	NULL
F.	NULL
C.	NULL
Brousse	NULL
,	NULL
T.	NULL
Hoey	NULL
,	NULL
M.	NULL
J.	NULL
Grusby	NULL
,	NULL
and	NULL
L.	NULL
H.	NULL
Glimcher	NULL
.	NULL

1996	NULL
.	NULL

Hyperproliferation	NULL
and	NULL
dysregulation	NULL
of	NULL
IL-4	NULL
expression	NULL
in	NULL
NF-ATp-deficient	NULL
mice	NULL
.	NULL

Immunity	NULL
4:397	NULL
.	NULL

5	NULL
.	NULL

Flanagan	NULL
,	NULL
W.	NULL
M.	NULL
,	NULL
B.	NULL
Corthesy	NULL
,	NULL
R.	NULL
J.	NULL
Bram	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabiree	NULL
.	NULL

1991	NULL
.	NULL

Nuclear	NULL
association	NULL
of	NULL
a	NULL
T-cell	NULL
transcription	NULL
factor	NULL
blocked	NULL
by	NULL
FK-506	NULL
and	NULL
cyclosporin	NULL
A	NULL
.	NULL

Nature	NULL
352:803	NULL
.	NULL

6	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
P.	NULL
G.	NULL
McCaffrey	NULL
,	NULL
A.	NULL
V.	NULL
Valge	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1992	NULL
.	NULL

Nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
contains	NULL
Fos	NULL
and	NULL
Jun	NULL
.	NULL

Nature	NULL
356:801	NULL
.	NULL

7	NULL
.	NULL

Schreiber	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
mechanism	NULL
of	NULL
action	NULL
of	NULL
cyclosporin	NULL
A	NULL
and	NULL
FK506	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
13:136	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24.	NULL
.	NULL

Shaw	NULL
,	NULL
K.	NULL
T.	NULL
,	NULL
A.	NULL
M.	NULL
Ho	NULL
,	NULL
A.	NULL
Raghavan	NULL
,	NULL
J.	NULL
Kim	NULL
,	NULL
J.	NULL
Jain	NULL
,	NULL
J	NULL
.	NULL

Park	NULL
,	NULL
S.	NULL
Sharma	NULL
,	NULL
A.	NULL
Rao	NULL
,	NULL
and	NULL
P.	NULL
G.	NULL
Hogan	NULL
.	NULL

1995	NULL
.	NULL

Immunosupressive	NULL
drugs	NULL
prevent	NULL
a	NULL
rapid	NULL
dephosphory-lation	NULL
of	NULL
transcription	NULL
factor	NULL
NFAT1	NULL
in	NULL
stimulated	NULL
immune	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:11205.	NULL
.	NULL

Hoey	NULL
,	NULL
T.	NULL
,	NULL
Y.	NULL
L.	NULL
Sun	NULL
,	NULL
K.	NULL
Williamson	NULL
,	NULL
and	NULL
X.	NULL
Xu	NULL
.	NULL

1995	NULL
.	NULL

Isolation	NULL
of	NULL
two	NULL
new	NULL
members	NULL
of	NULL
the	NULL
NF-AT	NULL
gene	NULL
family	NULL
and	NULL
functional	NULL
characterization	NULL
of	NULL
the	NULL
NF-AT	NULL
proteins	NULL
.	NULL

Immunity	NULL
2:461	NULL
.	NULL

Masuda	NULL
,	NULL
E.	NULL
S.	NULL
,	NULL
Y.	NULL
Naito	NULL
,	NULL
H.	NULL
Tokumitsu	NULL
,	NULL
D.	NULL
Campbell	NULL
,	NULL
F.	NULL
Saito	NULL
,	NULL
C.	NULL
Hannum	NULL
,	NULL
K.	NULL
Arai	NULL
,	NULL
and	NULL
N.	NULL
Arai	NULL
.	NULL

1995	NULL
.	NULL

NFATx	NULL
,	NULL
a	NULL
novel	NULL
member	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
family	NULL
that	NULL
is	NULL
expressed	NULL
predominantly	NULL
in	NULL
the	NULL
thymus	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:2697	NULL
.	NULL

McCaifftey	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
C.	NULL
Luo	NULL
,	NULL
T.	NULL
K.	NULL
Kerppola	NULL
,	NULL
J.	NULL
Jain	NULL
,	NULL
T.	NULL
M.	NULL
Badalian	NULL
,	NULL
A.	NULL
M.	NULL
Ho	NULL
,	NULL
E.	NULL
Burgeon	NULL
,	NULL
W.	NULL
S.	NULL
Lane	NULL
,	NULL
J.	NULL
N.	NULL
Lambert	NULL
,	NULL
T.	NULL
Curran	NULL
,	NULL
G.	NULL
L.	NULL
Verdine	NULL
,	NULL
A.	NULL
Rao	NULL
,	NULL
and	NULL
P.	NULL
G.	NULL
Hogan	NULL
.	NULL

1993	NULL
.	NULL

Isolation	NULL
of	NULL
the	NULL
cyclosporin-sensitive	NULL
T	NULL
cell	NULL
transcription	NULL
factor	NULL
NF-ATp	NULL
.	NULL

Science	NULL
262:750	NULL
.	NULL

Northrop	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
S.	NULL
N.	NULL
Ho	NULL
,	NULL
L.	NULL
Chen	NULL
,	NULL
D.	NULL
J.	NULL
Thomas	NULL
,	NULL
L.	NULL
A.	NULL
Timmerman	NULL
,	NULL
G.	NULL
P.	NULL
Nolan	NULL
,	NULL
A.	NULL
Admon	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1994	NULL
.	NULL

NFAT	NULL
components	NULL
define	NULL
a	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
targeted	NULL
in	NULL
T-cell	NULL
activation	NULL
.	NULL

Nature	NULL
369:497	NULL
.	NULL

Ho	NULL
,	NULL
S.	NULL
N.	NULL
,	NULL
D.	NULL
J.	NULL
Thomas	NULL
,	NULL
L.	NULL
A.	NULL
Timmerman	NULL
,	NULL
X.	NULL
Li	NULL
,	NULL
U.	NULL
Francke	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1995	NULL
.	NULL

NFATc3	NULL
,	NULL
a	NULL
lymphoid-specific	NULL
NFATc	NULL
family	NULL
member	NULL
that	NULL
is	NULL
calcium-regulated	NULL
and	NULL
exhibits	NULL
distinct	NULL
DNA	NULL
binding	NULL
specificity	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:19898	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
E.	NULL
Burgeon	NULL
,	NULL
T.	NULL
M.	NULL
Badalian	NULL
,	NULL
P.	NULL
G.	NULL
Hogan	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1995	NULL
.	NULL

A	NULL
similar	NULL
DNA-binding	NULL
motif	NULL
in	NULL
NFAT	NULL
family	NULL
proteins	NULL
and	NULL
the	NULL
Rel	NULL
homology	NULL
region	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:4138	NULL
.	NULL

Nolan	NULL
,	NULL
G.	NULL
P.	NULL
1994	NULL
.	NULL

NF-AT-AP-1	NULL
and	NULL
Rel-bZIP	NULL
:	NULL
hybrid	NULL
vigor	NULL
and	NULL
binding	NULL
under	NULL
the	NULL
influence	NULL
.	NULL

Cell	NULL
77:795	NULL
.	NULL

Masuda	NULL
,	NULL
E.	NULL
S.	NULL
,	NULL
J.	NULL
Liu	NULL
,	NULL
R.	NULL
Imamura	NULL
,	NULL
S.	NULL
Imai	NULL
,	NULL
K.	NULL
Arai	NULL
,	NULL
and	NULL
N.	NULL
Arai	NULL
.	NULL

1997	NULL
.	NULL

Control	NULL
of	NULL
NFATx1	NULL
nuclear	NULL
translocation	NULL
by	NULL
a	NULL
calcineurin-regulated	NULL
inhibitory	NULL
domain	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

17:2066	NULL
.	NULL

Loh	NULL
,	NULL
C.	NULL
,	NULL
K.	NULL
T.-Y	NULL
.	NULL

Shaw	NULL
,	NULL
J.	NULL
Carew	NULL
,	NULL
J.	NULL
P.	NULL
B.	NULL
Viola	NULL
,	NULL
C.	NULL
Luo	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Perrino	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1996	NULL
.	NULL

Calcineurin	NULL
binds	NULL
the	NULL
transcription	NULL
factor	NULL
NFAT1	NULL
and	NULL
reversibly	NULL
regulates	NULL
its	NULL
activity	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:10884	NULL
.	NULL

Shibasaki	NULL
,	NULL
F.	NULL
,	NULL
E.	NULL
R.	NULL
Price	NULL
,	NULL
D.	NULL
Milan	NULL
,	NULL
and	NULL
F.	NULL
McKeon	NULL
.	NULL

1996	NULL
.	NULL

Role	NULL
of	NULL
kinases	NULL
and	NULL
the	NULL
phosphatase	NULL
calcineurin	NULL
in	NULL
the	NULL
nuclear	NULL
shuttling	NULL
of	NULL
transcription	NULL
factor	NULL
NF-AT4	NULL
.	NULL

Nature	NULL
382:370	NULL
.	NULL

Imai	NULL
,	NULL
S.	NULL
,	NULL
T.	NULL
Fujino	NULL
,	NULL
S.	NULL
Nishibayashi	NULL
,	NULL
T.	NULL
Manabe	NULL
,	NULL
and	NULL
T.	NULL
Takano	NULL
.	NULL

1994	NULL
.	NULL

Immor-talization-susceptible	NULL
elements	NULL
and	NULL
their	NULL
binding	NULL
factors	NULL
mediate	NULL
rejuvenation	NULL
of	NULL
regulation	NULL
of	NULL
the	NULL
type	NULL
I	NULL
collagenase	NULL
gene	NULL
in	NULL
simian	NULL
virus	NULL
40	NULL
large	NULL
T	NULL
antigen-transformed	NULL
immortal	NULL
human	NULL
fibroblasts	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:7182	NULL
.	NULL

Tsuruta	NULL
,	NULL
L.	NULL
,	NULL
H.	NULL
J.	NULL
Lee	NULL
,	NULL
E.	NULL
S.	NULL
Masuda	NULL
,	NULL
N.	NULL
N.	NULL
Koyano	NULL
,	NULL
N.	NULL
Arai	NULL
,	NULL
K.	NULL
Arai	NULL
,	NULL
and	NULL
T.	NULL
Yokota	NULL
.	NULL

1995	NULL
.	NULL

Cyclic	NULL
AMP	NULL
inhibits	NULL
expression	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
through	NULL
the	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NF-AT	NULL
)	NULL
site	NULL
,	NULL
and	NULL
transfection	NULL
of	NULL
NF-AT	NULL
cDNAs	NULL
abrogates	NULL
the	NULL
sensitivity	NULL
of	NULL
EL-4	NULL
cells	NULL
to	NULL
cyclic	NULL
AMP	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

154	NULL
:	NULL
5255	NULL
.	NULL

Lee	NULL
,	NULL
H.	NULL
J.	NULL
,	NULL
E.	NULL
S.	NULL
Masuda	NULL
,	NULL
N.	NULL
Arai	NULL
,	NULL
K.	NULL
Arai	NULL
,	NULL
and	NULL
T.	NULL
Yokota	NULL
.	NULL

1995	NULL
.	NULL

Definition	NULL
of	NULL
cis-regulatory	NULL
elements	NULL
of	NULL
the	NULL
mouse	NULL
interleukin-5	NULL
gene	NULL
promoter	NULL
:	NULL
involvement	NULL
of	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cell-related	NULL
factors	NULL
in	NULL
interleukin-5	NULL
expression	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:17541	NULL
.	NULL

Heike	NULL
,	NULL
T.	NULL
,	NULL
S.	NULL
Miyatake	NULL
,	NULL
M.	NULL
Yoshida	NULL
,	NULL
K.	NULL
Arai	NULL
,	NULL
and	NULL
N.	NULL
Arai	NULL
.	NULL

1989	NULL
.	NULL

Bovine	NULL
papil-loma	NULL
virus	NULL
encoded	NULL
E2	NULL
protein	NULL
activates	NULL
lymphokine	NULL
genes	NULL
through	NULL
DNA	NULL
ele-ments	NULL
,	NULL
distinct	NULL
from	NULL
the	NULL
consensus	NULL
motif	NULL
,	NULL
in	NULL
the	NULL
long	NULL
control	NULL
region	NULL
of	NULL
its	NULL
own	NULL
genome	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

8:1411	NULL
.	NULL

Ausubel	NULL
,	NULL
F.	NULL
M.	NULL
,	NULL
R.	NULL
Brent	NULL
,	NULL
R.	NULL
E.	NULL
Kingston	NULL
,	NULL
D.	NULL
D.	NULL
Moore	NULL
,	NULL
J.	NULL
G.	NULL
Seidman	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Smith	NULL
,	NULL
and	NULL
K.	NULL
Struhl	NULL
,	NULL
eds	NULL
.	NULL

1987	NULL
.	NULL

Current	NULL
Protocols	NULL
in	NULL
Molecular	NULL
Biology	NULL
.	NULL

Greene	NULL
Publishing	NULL
Associates	NULL
and	NULL
Wiley-Interscience	NULL
,	NULL
New	NULL
York	NULL
,	NULL
N.Y.	NULL
Masuda	NULL
,	NULL
E.	NULL
S.	NULL
,	NULL
H.	NULL
Tokumitsu	NULL
,	NULL
A.	NULL
Tsuboi	NULL
,	NULL
J.	NULL
Shlomai	NULL
,	NULL
P.	NULL
Hung	NULL
,	NULL
K.	NULL
Arai	NULL
,	NULL
and	NULL
N.	NULL
Arai	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
promoter	NULL
cis-acting	NULL
element	NULL
CLEO	NULL
mediates	NULL
induction	NULL
signals	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
is	NULL
recognized	NULL
by	NULL
factors	NULL
related	NULL
to	NULL
AP1	NULL
and	NULL
NFAT	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:7399	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

3463	NULL
Emmel	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
C.	NULL
L.	NULL
Verweij	NULL
,	NULL
D.	NULL
B.	NULL
Durand	NULL
,	NULL
K.	NULL
M.	NULL
Higgins	NULL
,	NULL
E.	NULL
Lacy	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabiree	NULL
.	NULL

1989	NULL
.	NULL

Cyclosporin	NULL
A	NULL
specifically	NULL
inhibits	NULL
function	NULL
of	NULL
nuclear	NULL
proteins	NULL
involved	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Science	NULL
246:1617	NULL
.	NULL

Triezenberg	NULL
,	NULL
S.	NULL
J	NULL
.	NULL

1995	NULL
.	NULL

Structure	NULL
and	NULL
function	NULL
of	NULL
transcriptional	NULL
activation	NULL
do-mains	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Genet	NULL
.	NULL

Dev	NULL
.	NULL

5:190	NULL
.	NULL

Meijer	NULL
,	NULL
N.	NULL
,	NULL
A.	NULL
Graus	NULL
,	NULL
and	NULL
G.	NULL
Grosveld	NULL
.	NULL

1992	NULL
.	NULL

Mapping	NULL
the	NULL
transactivation	NULL
domain	NULL
of	NULL
the	NULL
Oct-6	NULL
POU	NULL
transcription	NULL
factor	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

20:2241	NULL
.	NULL

Attardi	NULL
,	NULL
L.	NULL
D.	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1993	NULL
.	NULL

Drosophila	NULL
tissue	NULL
specific	NULL
transcription	NULL
factor	NULL
NTF-1	NULL
contains	NULL
a	NULL
novel	NULL
isoleucine-rich	NULL
activation	NULL
motif	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

7:1341	NULL
.	NULL

Munoz	NULL
,	NULL
V.	NULL
,	NULL
and	NULL
L.	NULL
Serrano	NULL
.	NULL

1995	NULL
.	NULL

Helix	NULL
design	NULL
,	NULL
prediction	NULL
and	NULL
stability	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Biotechnol	NULL
.	NULL

6:382	NULL
.	NULL

Caldenhoven	NULL
,	NULL
E.	NULL
,	NULL
D.	NULL
T.	NULL
van	NULL
Dijk	NULL
,	NULL
R.	NULL
Solari	NULL
,	NULL
J.	NULL
Armstrong	NULL
,	NULL
J.	NULL
Raaijmakers	NULL
,	NULL
J.	NULL
Lammers	NULL
,	NULL
L.	NULL
Koenderman	NULL
,	NULL
and	NULL
R.	NULL
P.	NULL
de	NULL
Groot	NULL
.	NULL

1996	NULL
.	NULL

STAT3B	NULL
,	NULL
a	NULL
splice	NULL
variant	NULL
of	NULL
transcription	NULL
factor	NULL
STAT3	NULL
,	NULL
is	NULL
a	NULL
dominant	NULL
negative	NULL
regulator	NULL
of	NULL
transcription	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:13221	NULL
.	NULL

Bach	NULL
,	NULL
I.	NULL
,	NULL
and	NULL
M.	NULL
Yaniv	NULL
.	NULL

1993	NULL
.	NULL

More	NULL
potent	NULL
transcriptional	NULL
activators	NULL
or	NULL
a	NULL
trans-dominant	NULL
inhibitor	NULL
of	NULL
the	NULL
HNF1	NULL
homeoprotein	NULL
family	NULL
are	NULL
generated	NULL
by	NULL
alternative	NULL
RNA	NULL
processing	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:4229	NULL
.	NULL

Matsui	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
S.	NULL
Sashihara	NULL
.	NULL

1995	NULL
.	NULL

Tissue-specific	NULL
distribution	NULL
of	NULL
a	NULL
novel	NULL
C-terminal	NULL
truncation	NULL
retinoic	NULL
acid	NULL
receptor	NULL
mutant	NULL
which	NULL
acts	NULL
as	NULL
a	NULL
negative	NULL
repres-sor	NULL
in	NULL
a	NULL
promoter-	NULL
and	NULL
cell-type-specific	NULL
manner	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:1961	NULL
.	NULL

Jie	NULL
,	NULL
L..	NULL
,	NULL
N.	NULL
Koyano-Nakagawa	NULL
,	NULL
Y.	NULL
Amasaki	NULL
,	NULL
F.	NULL
Saito-Ohara	NULL
,	NULL
T.	NULL
Ikeuchi	NULL
,	NULL
S.	NULL
Imai	NULL
,	NULL
T.	NULL
Takano	NULL
,	NULL
N.	NULL
Arai	NULL
,	NULL
T.	NULL
Yokota	NULL
,	NULL
and	NULL
K.	NULL
Arai	NULL
.	NULL

1997	NULL
.	NULL

Calcineurin	NULL
dependent	NULL
nuclear	NULL
translocation	NULL
of	NULL
a	NULL
murine	NULL
transcription	NULL
factor	NULL
NFATx	NULL
:	NULL
molecular	NULL
cloning	NULL
and	NULL
functional	NULL
characterization	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Cell	NULL
8:157	NULL
.	NULL

Wang	NULL
,	NULL
D.	NULL
Z.	NULL
,	NULL
P.	NULL
G.	NULL
McCaifftey	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
cyclosporin-sensitive	NULL
transcription	NULL
factor	NULL
NFATp	NULL
is	NULL
expressed	NULL
in	NULL
several	NULL
classes	NULL
of	NULL
cells	NULL
in	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

Ann	NULL
.	NULL

NY	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

766:182	NULL
.	NULL

Luo	NULL
,	NULL
C.	NULL
,	NULL
E.	NULL
Burgeon	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Carew	NULL
,	NULL
P.	NULL
G.	NULL
McCaiffty	NULL
,	NULL
T.	NULL
M.	NULL
Badalian	NULL
,	NULL
W.	NULL
S.	NULL
Lane	NULL
,	NULL
P.	NULL
G.	NULL
Hogan	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1996	NULL
.	NULL

Recombinant	NULL
NFAT1	NULL
(	NULL
NFATp	NULL
)	NULL
is	NULL
regulated	NULL
by	NULL
calcineurin	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
mediates	NULL
transcription	NULL
of	NULL
several	NULL
cytokine	NULL
genes	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:3955	NULL
.	NULL

Park	NULL
,	NULL
J.	NULL
,	NULL
A.	NULL
Takeuchi	NULL
,	NULL
and	NULL
S.	NULL
Sharma	NULL
.	NULL

1996	NULL
.	NULL

Characterization	NULL
of	NULL
a	NULL
new	NULL
isoform	NULL
of	NULL
the	NULL
NFAT	NULL
(	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
)	NULL
gene	NULL
family	NULL
member	NULL
NFAT	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:20914	NULL
.	NULL

Bamford	NULL
,	NULL
R.	NULL
N.	NULL
,	NULL
A.	NULL
P.	NULL
Battiata	NULL
,	NULL
and	NULL
T.	NULL
A.	NULL
Waldmann	NULL
.	NULL

1996	NULL
.	NULL

IL-15	NULL
:	NULL
the	NULL
role	NULL
of	NULL
translational	NULL
regulation	NULL
in	NULL
their	NULL
expression	NULL
.	NULL

J.	NULL
Leukocyte	NULL
Biol	NULL
.	NULL

59:476	NULL
.	NULL

Grabstein	NULL
,	NULL
K.	NULL
H.	NULL
,	NULL
J.	NULL
Eisenman	NULL
,	NULL
K.	NULL
Shanebeck	NULL
,	NULL
C.	NULL
Rauch	NULL
,	NULL
S.	NULL
Srinivasan	NULL
,	NULL
V.	NULL
Fung	NULL
,	NULL
C.	NULL
Beers	NULL
,	NULL
J.	NULL
Richardson	NULL
,	NULL
M.	NULL
A.	NULL
Schoenborn	NULL
,	NULL
M.	NULL
Ahdich	NULL
,	NULL
L.	NULL
Johnson	NULL
,	NULL
M.	NULL
R.	NULL
Alderson	NULL
,	NULL
J.	NULL
D.	NULL
Watson	NULL
,	NULL
D.	NULL
M.	NULL
Anderson	NULL
,	NULL
and	NULL
J.	NULL
G.	NULL
Giri	NULL
.	NULL

1994	NULL
.	NULL

Cloning	NULL
of	NULL
a	NULL
T	NULL
cell	NULL
growth	NULL
factor	NULL
that	NULL
interacts	NULL
with	NULL
the	NULL
3	NULL
chain	NULL
of	NULL
the	NULL
interleukin-2	NULL
receptor	NULL
.	NULL

Science	NULL
264:965	NULL
.	NULL

Ranger	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
M.	NULL
J.	NULL
Grusby	NULL
,	NULL
M.	NULL
R.	NULL
Hodge	NULL
,	NULL
E.	NULL
M.	NULL
Gravallese	NULL
,	NULL
F.	NULL
C.	NULL
de	NULL
la	NULL
Brousse	NULL
,	NULL
T.	NULL
Hoey	NULL
,	NULL
C.	NULL
Mickanin	NULL
,	NULL
H.	NULL
S.	NULL
Baldwin	NULL
,	NULL
and	NULL
L.	NULL
H.	NULL
Glimcher	NULL
.	NULL

1998	NULL
.	NULL

The	NULL
transcription	NULL
factor	NULL
NF-ATc	NULL
is	NULL
essential	NULL
for	NULL
cardiac	NULL
valve	NULL
formation	NULL
.	NULL

Nature	NULL
392:186.	NULL
de	NULL
la	NULL
Pompa	NULL
,	NULL
J.	NULL
,	NULL
L.	NULL
A.	NULL
Timmerman	NULL
,	NULL
H.	NULL
Takimoto	NULL
,	NULL
H.	NULL
Yoshida	NULL
,	NULL
A.	NULL
J.	NULL
Elia	NULL
,	NULL
E.	NULL
Samper	NULL
,	NULL
J.	NULL
Potter	NULL
,	NULL
A.	NULL
Wakeham	NULL
,	NULL
L.	NULL
Marengere	NULL
,	NULL
B.	NULL
L.	NULL
Langille	NULL
,	NULL
G.	NULL
R.	NULL
Crabtree	NULL
,	NULL
and	NULL
T.	NULL
W.	NULL
Mak	NULL
.	NULL

1998	NULL
.	NULL

Role	NULL
of	NULL
the	NULL
NF-ATe	NULL
transcription	NULL
factor	NULL
in	NULL
morphogenesis	NULL
of	NULL
cardiac	NULL
valves	NULL
and	NULL
septum	NULL
.	NULL

Nature	NULL
392:182	NULL
.	NULL

Molkentin	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
J.	NULL
Lu	NULL
,	NULL
C.	NULL
L.	NULL
Antos	NULL
,	NULL
B.	NULL
Markham	NULL
,	NULL
J.	NULL
Richardson	NULL
,	NULL
J.	NULL
Robbins	NULL
,	NULL
S.	NULL
R.	NULL
Grant	NULL
,	NULL
and	NULL
E.	NULL
N.	NULL
Olson	NULL
.	NULL

1998	NULL
.	NULL

A	NULL
calcineurin-dependent	NULL
transcriptional	NULL
pathway	NULL
for	NULL
cardiac	NULL
hypertrophy	NULL
.	NULL

Cell	NULL
93:215	NULL
.	NULL

Xanthoudakis	NULL
,	NULL
S.	NULL
,	NULL
J.	NULL
P.	NULL
B.	NULL
Biola	NULL
,	NULL
K.	NULL
T.-Y	NULL
.	NULL

Shaw	NULL
,	NULL
C.	NULL
Luo	NULL
,	NULL
J.	NULL
D.	NULL
Wallace	NULL
,	NULL
P.	NULL
T.	NULL
Bozza	NULL
,	NULL
T.	NULL
Curran	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1996	NULL
.	NULL

An	NULL
enhanced	NULL
immune	NULL
response	NULL
in	NULL
mice	NULL
lacking	NULL
the	NULL
transcription	NULL
factor	NULL
NFAT1	NULL
.	NULL

Science	NULL
272:892	NULL
.	NULL

Shi	NULL
,	NULL
P.	NULL
,	NULL
N.	NULL
Koyano-Nakagawa	NULL
,	NULL
L.	NULL
Tsuruta	NULL
,	NULL
Y.	NULL
Amasaki	NULL
,	NULL
T.	NULL
Yokota	NULL
,	NULL
S.	NULL
Mori	NULL
,	NULL
N.	NULL
Arai	NULL
,	NULL
and	NULL
K.	NULL
Arai	NULL
.	NULL

1997	NULL
.	NULL

Molecular	NULL
cloning	NULL
and	NULL
functional	NULL
characterization	NULL
of	NULL
murine	NULL
cDNA	NULL
encoding	NULL
transcription	NULL
factor	NULL
NFATc	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

240:314	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL

